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ABSTRACT 
Two Src family tyrosine kinases Lck and Fyn are critical for the proximal T-cell 
signalling. Previously it was demonstrated that antibody-induced Lck activation outside 
lipid rafts (LR) results in Lck translocation to LR. Central in this event is the rapid 
translocation of kinase active Lck to LR, yet the mechanism underpinning this process 
is unknown. The main aim of this study is the characterization of molecular 
mechanisms and its functional elements regulating the early recruitment of signalling 
molecules to LR and forming immunological synapse. We have recently characterized 
the C-terminal YQPQP sequence as a novel cis-acting component essential for Lck 
partitioning to LR. In this context, the expression of the C-terminal truncate of 
constitutively active Lck ( FQPQP) in NIH3T3 cells failed to phosphorylate several 
proteins detected in the presence of untruncated kinase active Y505F-Lck. Comparative 
2-D gel analyses followed by MS/MALDI identified RACK1 as a candidate protein for 
interaction with the C-terminal tail of Lck. Co-expression in NIH3T3 cells of RACK1 
with either a wild type Lck or constitutively active Y505F-Lck revealed the complex 
formation between Y505F-Lck, but not WT-Lck, and RACK1. Ectopic expression of 
Y505F-Lck with its domain-inactivating mutations showed that Lck-RACK1 interaction 
depends on functional SH2 and SH3 domains, and the C-terminal tail sequence of Lck. 
Importantly, Lck-RACK1 interaction is readily detectable also in primary CD4
+
 lymph 
node T-cells. Upon their activation, only the pool of Lck associated with the high 
molecular weight complexes translocates to lipid rafts. Co-purification of RACK1 with 
these fractions further suggests that it plays a role in the translocation of Lck to LR. 
This RACK1 function is further strengthened by observations that Lck and RACK1  
co-redistribute to both antibody-mediated capping clusters and forming immunological 
synapses. Moreover, the importance of interaction between activated Lck and RACK1 
in the context of Lck translocation mechanism to LR is further supported by data 
pointing to RACK1 association with elements of microtubular network. In aggregate, 
these results are the first to characterize RACK1 as a candidate molecule involved in the 
regulation of Lck translocation to LR by providing the link between Lck and 
cytoskeletal network. 
 
Key Words: Lck, RACK1, Lipid Raft, T-cell activation, CD4
+
 T-cell, Translocation 
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ABSTRAKT (CZ) 
Dvě kinázy z rodiny Src, Lck a Fyn, jsou kriticky důležité pro zahájení časné T-buněčné 
signalizace. Předchozí experimenty prokázály, že aktivace kinázy Lck nacházející se 
mimo lipidové rafty (LR) vede k jejímu rychlému přesunu do těchto struktur. 
Mechanismus vysvětlující tento proces není dosud znám. Hlavním cílem této práce je 
charakterizace molekulárního mechanismu a jeho funkčních elementů, které se podílejí 
na regulaci časného přesunu signálních molekul do LR a vytváření imunologické 
synapse. Nedávno jsme charakterizovali C-terminální YQPQP sekvenci Lck jako novou 
komponentu důležitou pro lokalizaci Lck do LR. Bylo prokázáno, že odstranění  
C-terminálního konce konstitutivně aktivní Lck (ΔFQPQP-Lck) v NIH3T3 buňkách 
znemožňuje fosforylaci řady proteinů, které jsou detekovány v přítomnosti nezkrácené 
aktivní kinázy Y505F-Lck. Komparativní analýzou tohoto rozdílného fosforylačního 
statutu pomocí 2D-gelové elektroforézy a následné MS/MALDI byl identifikován 
protein RACK1 jako vhodný kandidát pro interakci s C-terminální částí Lck. Společná 
exprese proteinu RACK1 s divým typem Lck (WT-Lck) anebo konstitutivně aktivní 
formou Y505F-Lck v NIH3T3 buňkách prokázala formování komplexu mezi RACK1 a 
Y505F-Lck, ale ne s WT-Lck. Exprese Y505F-Lck s inaktivujícími mutacemi ukázala, 
že Lck-RACK1 interakce zavisí na přítomnosti funkčních domén SH2, SH3 a  
C-terminální sekvence Lck. Interakci Lck-RACK1 je také možno detekovat 
v primárních CD4+ T-buňkách izolovaných z lymfatických uzlin. Po jejich aktivaci, 
pouze ta část Lck molekul, které jsou asociovany s vysokomolekulárními komplexy se 
může přemístit do LR. Přítomnost RACK1 ve stejných frakcích poukazuje na to, že 
tento protein může hrát úlohu v translokaci Lck do LR. Navíc Lck i RACK1 se společně 
přesouvají do formující se imunologické synapse i protilátkami indukovaných klastrů. 
Důležitost interakcí mezi aktivovanou Lck a RACK1 v kontextu tohoto translokačního 
mechanismu podtrhuje též zjištění, že RACK1 je associován i s mikrotubulárním 
cytoskeletem. Ve shrnutí, tyto výsledky jako první popisují protein RACK1 jako 
kandidátní molekulu účastnící se regulace přesunu kinázy Lck do LR prostřednictvím 
napojení Lck na cytoskeletární síť. 
 
Klíčová slova: Lck, RACK1, Lipidové Rafty, T-buněčná signalizace, CD4+  
T-lymfocyt, Translokace  
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1 Introduction 
Immunity, a vital component of life systems, is a very important part of our defence 
against various threats of danger, either self- or non-self derived. It protects us from 
pathogen attacks, environment changes, genetic disorders etc., but sometimes it also can 
be harmful for ourselves. We tend to divide immune responses into two modules – 
innate, non-specific and adaptive, or acquired. Both components actively cooperate and 
communicate with each other via direct cell-cell interactions or indirectly through a 
release of cytokine and chemokine mediators and thus creating a highly integrated and 
coordinated network of communication channels.  
This study is focused on T lymphocytes, also called T-cells that play a fundamental role 
in adaptive immunity. There are two major subsets of T-cells: CD4
+
 helper T-cells and 
CD8
+
 cytotoxic T-cells, both being able to recognize antigens presented on the surface 
of Antigen Presenting Cells (APC) in the context of MHC class II and MHC class I 
molecules, respectively. An antigen-mediated T-cell:APC interaction leads to the 
initiation of T-cell activation and triggering of downstream signalling pathways, 
resulting in the global changes in gene expression. Despite a controversy surrounding 
the physiological and structural heterogeneity of plasma membrane (Munro, 2003), the 
involvement of membrane microdomains called Lipid Rafts (LR) in T-cell activation is 
well established (Horejsi, 2003). In this context, LR form very dynamic membrane 
clusters that contain a set of important signalling molecules and thus provide the 
platform for their membrane distribution in non-activated T-cells. Importantly, LR have 
been shown to be also involved in the regulation of spatio-temporal redistribution of 
signalling molecules during the onset of T-cell activation. It has been suggested that 
these early membrane translocation events are controlled by cytoskeleton network 
(Viola and Gupta, 2007). However, the mechanism linking the T-cell Receptor (TCR) 
engagement with the initiation of cytoskeleton reorganization remains largely unknown.  
Two Src Family tyrosine Kinases (SFK) Lck and Fyn are critical for the proximal T-cell 
signalling. It has been previously demonstrated that antibody-induced Lck activation 
outside LR results in Lck translocation to LR (Filipp, 2003). Central in this event is the 
rapid translocation of kinase active Lck to LR. Thus, the main aim of our study is the 
characterization of molecular mechanism(s) and its functional elements regulating the 
early recruitment of signalling molecules to LR and forming immunological synapse. 
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Using the fibroblast model system, we previously identified several candidate proteins 
potentially involved in the process of Lck membrane distribution. Here, we report the 
first characterization of one of these candidate proteins, called RACK1, as the molecule 
involved in regulation of translocation of Lck to LR through linking the Lck kinase to 
cytoskeletal network.  
 
 
2 Literature Review 
This section details the current view on T-cell activation process with emphasis on the 
initiation of TCR signalling and activation of critically important signalling cascades. 
The model presented describes various molecular components of these signalling 
pathways, including TCR receptor, CD4 and CD28 co-receptors and two Src-family 
kinases Lck and Fyn, mechanism of their interactions, and their specific roles in signal 
transduction process. Further, it highlights the induction of cytoskeletal reorganization 
and changes in gene expression as the consequence of these initial signalling events. It 
also characterizes LR as very important structural components of plasma membrane for 
the initiation of T-cell signalling. Further, the relationships between these three major 
players (signalling molecules, LR, cytoskeleton) that together orchestrate the highly 
regulated process of T-cell activation leading to the formation of Immunological 
Synapse (IS) and ultimately resulting in full activation of effector T-cells, is reviewed. 
At the end, we briefly describe the structure and function of the protein called Receptor 
for Activated C Kinase 1 (RACK1). This molecule discovered some time ago has been 
shown to serve as a scaffold protein for several isoforms of Protein Kinase C (PKC) as 
well as for SFKs.  Data presented in this study identified RACK1 protein as an 
important cytoskeletal element supporting the translocation of Lck kinase to LR in early 
phases of T-cell activation.  
 
2.1 Activation of T-cells: two signals required  
T-cell activation begins by TCR-mediated recognition of specific antigens presented on 
APCs, usually dendritic cells (DC), macrophages or B-cells. Antigens are always 
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presented in the context of the Major Histocompatibility Complex glycoproteins class I 
or II (MHCI or MHCII) in a form of short peptide fragments, usually 10-20 amino acids 
long. They can be of self- or non-self origin (endo- or exo-genous, respectively). Upon 
recognition of peptide-MHC complexes (pMHC), TCR molecules expressed on the 
surface of T-cells, bind to pMHC complexes and this binding is considered to be an 
initiation point (foundation-stone) for the formation of IS (see below). Beside this 
interaction which provides the first activation signal for T-cells, the second, so called 
co-stimulatory signal is also required for full T-cell activation (Lenschow et al., 1996). 
Co-stimulation is provided by interactions between B7-family members expressed on 
APCs (B7.1/CD80 and/or B7.2/CD86) and their ligand CD28 present on T-cells.  
 
2.2 Three phases of T-cell activation process  
T-cell priming and formation of immunological synapse is a very dynamic process 
involving several successive stages that all together last for a relatively long time, 
approximately 24-48 hours. Using an in vivo model of T-cell activation, Ulrich von 
Andrian and colleagues (Mempel et al., 2004) distinguished 3 phases occurring during 
T-cell priming by DCs. Naïve T-cells leave the thymus and migrate into secondary 
lymphoid organs (lymph nodes and spleen) where they scan the surface of APCs for 
presence of cognate ligands. In the first phase, T-cells and DCs form short-lived 
contacts lasting approx. 5-30 minutes. Initial contacts induce an early T-cell activation 
which is sufficient for expression of early activation markers like CD44 and CD69, but 
not for upregulation of IL-2α-receptor subunit (CD25). After this initial phase, T-cell 
motion slows down and stable conjugates between T-cells and DCs are formed. These 
interactions, characteristic for the phase two of T-cell activation process, continue for 
about 16 hours, when almost all activation markers on T-cell surface, including CD25, 
are readily detectable. However, even though the formation of mature immunological 
synapse with clearly defined borders of Supramolecular Activation Cluster (SMAC) in 
contact zones is completed (Lee et al., 2002), T-cell proliferation is still not initiated or 
is on very low levels. The third phase continues approximately one day after naïve T-
cell entered lymph nodes and spleen. T-cell:APC conjugates dissociate and fully 
activated T-cells produce IL-2 cytokine, rapidly divide and leave secondary lymphoid 
tissues. 
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2.3 The structure of the immunological synapse.  
Interface structure of apposing membranes formed during the initial stages of cell-cell 
interaction between APC and T-cell is called an immunological synapse (Grakoui et al., 
1999). Lymphocyte polarization and co-clustering of important signalling molecules 
and cytoskeleton compounds into T-cell:APC contact zone occur as a response to 
recognition of specific antigen-MHC complexes by antigen-specific T-cells. Consistent 
with cellular events accompanying T-cell priming, several phases recognized on 
molecular level are distinguished during the formation of IS [reviewed in (Friedl et al., 
2005)]. Briefly, during the initial phase, T-cells scan APCs for the presence of cognate 
antigens. Once they find it, interaction of T-cell adhesion molecules LFA1 and ICAM1 
with their ligands expressed on APCs transiently retards the motion of T-cells. Phase 2, 
which follows, is the most important one and will be reviewed in detail later. Suffice to 
mention at this point that within a few seconds after T-cell:APC contact is established, 
multiple signalling pathway are triggered, resulting in the activation of a cascade of 
protein-protein interactions and cytoskeleton reorganization. Many positive and 
negative regulatory as well as feedback mechanisms controlling the dynamics, accuracy 
and amplitude of T-cell activation are in place (Fig 2.1A). Transition into the third 
phase is visible in about 30 minutes after antigen recognition and is sustained for 
several hours. At this point, the maturation of IS is already completed (Lee et al., 2002), 
because T-cell-APC contact site exhibits well-organized circular structures with nearly 
complete segregation of clustered molecules. Kupfer and colleagues (Monks et al., 
1998) modelled the mature IS as a structure consisting of three concentric rings: 
TCR/CD3 complex, CD28 receptor and PKCθ are localized in a central zone, known as 
a central supramolecular activation cluster (c-SMAC); LFA-1 adhesion molecules and 
CD4/Lck complexes are predominantly located in the peripheral ring surrounding  
c-SMAC (p-SMAC); and a distal zone containing mainly large molecules like CD45  
(d-SMAC) [reviewed in (Huppa and Davis, 2003)] (Fig. 2.1B).  
The above described distribution of signalling elements into concentric rings of SMAC 
is in most cases transient as these components can move in or out from one zone to the 
other. While the nature of these translocations is still obscure, they are required for 
delivery of regulatory and enzymatic functions of these signalling molecules. The last 
two phases (phase 4 and 5) contribute to downregulation and breakdown of IS. TCR and 
LFA1 dissociate from the contact zone and negative regulators, such as CTLA-4, are 
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upregulated. Concomitantly, motility of T-cells is renewed and their proliferation is 
initiated. 
Figure 2.1 Formation and composition of Immunological synapse. A. T-cell activation 
induced F-actin cytoskeletal rearrangement and polarization. The recruitment and activation of 
T-cell proximal signalling elements like Lck, ZAP70, LAT, SLP-76, Nck, Itk and Vav 
predicates the formation of immunological synapse which is dependent on F-actin 
polymerization. F-actin rearrangement is also required for the formation of new TCR 
microclusters which sustain TCR signalling as well as for the assembly of DPC. This complex, 
consisting of ERM and DLG1 proteins, functions as a depository area for negative regulators of 
T-cell signalling (taken from Billadeau et al., 2007). B. Crossection of T-cell:APC contact site. 
Three zones of SMAC are identified – central (c-SMAC): consisting mainly of TCR-MHC, 
CD28-CD80/CD86, PKCθ [brown]; periferal: co-receptors CD4/8, Lck, LFA1-ICAM1 [green] 
and distal: mainly CD45 [blue] (taken from Huppa and Davis, 2003). DPC-distal pole complex; 
SMAC- supramolecular activation cluster; 
 
2.4 Molecular signalling pathways in T-cell activation 
Simplified cartoon of T-cell signalling pathways are schematically illustrated in Figure 
2.4 (page 20).  Three critically important modules control the T-cell activation process: 
(i) Lck and Fyn regulation module; (ii) Signal triggering module; (iii) Signal 
diversification and regulation module. Brief description of these modules, 
characterization of their critical components and mechanism(s) controlling and 
integrating their effector functions are discussed below.  
A. B. 
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Of note, even though molecular mechanisms operating during the activation of CD4
+
 
and CD8
+
 T-cells are analogous, we emphasize that mechanisms of activation and their 
molecular elements described in following sections are largely derived from studies 
using CD4
+
 T-cells, and thus mostly relate to signalling events occurring in these cells.  
 
2.4.1 Lck and Fyn regulation module 
As Lck and Fyn provide critical enzymatic activities required for the initiation of 
proximal TCR signalling, activation and delivery of their functions are tightly regulated. 
Structure and mode of activation of Lck as the prototype of SFKs as well as regulatory 
molecules controlling the process of Lck activation are described below.  
 
2.4.1.1 Structure of Lck 
Lymphocyte-specific protein tyrosine kinase (Lck) plays an indispensable and crucial 
role in T-cell maturation and signalling. In its absence, thymocytes development as well 
as T-cell responses are severely compromised (Molina et al., 1992) what leads to 
various forms of immunodeficiency and/or autoimmunity diseases (Methi et al., 2005; 
Methi et al., 2007). 
Molecular weight of Lck is approximately 56 kDa and its structure, as illustrated in 
Figure 2.2, is highly conserved among other SFK members (Boggon and Eck, 2004). 
Lck has a short N-terminal region posttranslationally modified by double acylatation. 
These lipid modifications not only predispose Lck to the inner membrane leaflet of 
plasma membrane but also provide a targeting signal for docking it into distinct 
membrane micro-compartments called lipid rafts. The unique domain at N-terminal end 
of Lck is the least homologous among SFKs and facilitates a non-covalent interaction 
with co-receptors CD4 and CD8. The unique domain is followed by Src homology 3 
(SH3) and SH2 domains involved in mediating intramolecular and intermolecular 
interactions via binding to proline rich sequences and phosphotyrosine motifs, 
respectively. Following is the kinase domain and the C-terminal tail important for 
catalytic activity of Lck and its negative regulation, respectively.  
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Figure 2.2 Structure of Lck kinase.  Lck contains several regions and domains which are 
highly conserved among members of Src family tyrosine kinases: a short N-terminal, lipid-
modified region with one site for myristoylation (G2) and two potential sites for  palmitoylation 
(3C and 5C), a unique domain containing the binding site for co-receptor molecules CD4 and 
CD8, Src homology 3 (SH3) and SH2 domains recognizing prolin-rich and phosphotyrosine 
motifs, respectively, a linker region, a kinase domain responsible for catalytic function, and a C-
terminal tail involved in negative regulation of function via tyrosine at position Y505. The 
activatory tyrosine is positioned within the kinase domain at position 394 (Y394).  
 
2.4.1.2 Mechanism regulating kinase activity of Lck 
Intrinsic catalytic activity of kinase domain of Lck is negatively controlled via 
formation of two weak intramolecular interactions: (i) between the C-terminal pY505 
and SH2 domain and (ii) SH3 domain and polyproline-rich linker region. In this 
scenario, the kinase domain is held in an inactive, repressed conformation and the 
substrate accessibility is blocked (Mayer, 1997). While the phosphorylation of Y505 
residue is under the control of C-terminal Src kinase (Csk), pY505 dephosphorylation is 
executed by CD45 phosphatase which counteracts the action of Csk and results in open 
“primed” conformation of Lck (Fig. 2.3) (Hermiston et al., 2002; Palacios and Weiss, 
2004). The latter, coupled with the transphosphorylation of positive regulatory tyrosine 
residue Y394 is required for full kinase activity (Veillette et al., 2002).  
In summary, CD45 acts as positive regulator of Lck activity in contrast to Csk playing a 
negative regulatory role. How exactly is the equilibrium between these two opposing 
regulations established and how is this dynamic process controlled is not well 
understood. In this context it has been suggested that other proteins like the adaptor 
scaffold protein PAG/Cbp,  PEP phosphatase, adaptor proteins TSAD and Unc-119, to 
mention just a few, are also involved in Lck and Fyn regulatory loops (Brdicka et al., 
2000; Filby et al., 2007; Kawabuchi et al., 2000) (Fig. 2.3 and 2.4A). It is important to 
mention at this point that membrane microdomains, lipid rafts, add an additional level 
of complexity to these regulations as they serve as a platform for regulation of spatial 
17 
 
distribution and TCR-induced clustering and translocation of these effector molecules. 
The role of LR in proximal TCR signalling is highlighted below, in the section 2.7.2.  
Figure 2.3 Modelling the regulation of Lck activity: Lck has two important regulatory 
tyrosines – at position 505 (Y505, negative regulatory site) and at position 394 (Y394, positive 
regulatory site) phosphorylation of which regulate the activation status of Lck, negatively and 
positively, respectively. A. In resting T-cells, Lck Y505 tyrosine is phosphorylated by Csk 
kinase and pY505 then binds on self SH2 domain, keeping the kinase structure in “closed”, 
autoinhibited, inactive conformation. Dephosphorylation of Y505 tyrosine by CD45 
phosphatase “primes” Lck but the kinase is not fully active as the activatory tyrosine Y394 is 
not phophorylated. B. Upon TCR engagement and T-cell activation, primed Lck is clustered 
around TCR, what leads to its autotransphosphorylation on the activatory Y394 and this 
modification is required for the fully “active” state of Lck. In addition, upon activation, CD45 
or some other phosphatase(s) can dephosphorylate the adaptor protein PAG, resulting in the 
displacement of Csk from PAG and thus from the vicinity of Lck, keeping Lck active and 
disallowing its downregulation. (Taken from Hermiston et al., 2002). 
 
Besides Lck, another SFK member - Fyn is important for T-cell signalling and 
activation. It was previously believed that its function is more redundant and 
overlapping with that of Lck, however data accumulated in past few years indicate that 
it can play a distinct and more specific role(s) in proximal signalling, for example 
interaction with cytoskeleton regulators (Badour et al., 2004). In addition, it has been 
demonstrated that activation of Lck and Fyn kinases is sequential and unidirectional, 
Lck first then Fyn, and is temporarily and spatially uncoupled (Filipp and Julius, 2004) 
(see section 2.8). Moreover, many Lck- and Fyn-specific interaction partners were 
identified what underpins their independent and essential roles in T-cell activation 
(Zamoyska et al., 2003).  
A. B. 
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2.4.2 Signal triggering module  
An early T-cell activation process is control through several negative and positive 
regulatory feedbacks. It can arbitrary be divided into two phases:  (i) proximal early 
activation signals occurring during the first few 3-5 minute and late 5-30 minutes 
period, when the mature IS forms and production of IL-2 cytokine is induced. Brief 
description of TCR, auxiliary molecules and the mechanism underpinning the 
generation of TCR emanating signals is provided below (Fig. 2.4).  
 
2.4.2.1 T-cell receptor complex 
T-cell receptor (TCR) together with CD3 chains form TCR/CD3 complex which is 
responsible for antigen recognition and transmission of this signal to downstream 
effectors. Recognition ability is provided by TCR/MHC interaction. TCR is 
heterodimeric molecule where both α and β chains consist of variable and constant 
regions. Somatic rearrangement of TCR occurs during thymocyte development in the 
thymus and enables to generate an enormous repertoire of TCR variants able to 
recognize practically any antigenic peptide expressed in the context of MHC on APCs. 
As α and β chains of TCR have no functional connection to intracellular space, an 
engagement of TCR is translated to intracellular signalling elements via CD3 chains γ, 
δ, ε and ξ. All of them contain tyrosine phosphorylation sites within Immunoreceptor 
Tyrosine-based Activation Motifs (ITAM), which serve as docking sites for ξ-chain 
associated protein of 70kDa (ZAP-70) kinase.  
 
2.4.2.2 Auxiliary signalling elements 
Many other proteins contribute to early steps of T-cell signalling. CD4 and CD8 co-
receptors are able to bind through their extracellular portions to MHCII and MHCI, 
respectively, and significantly enhance T-cell responses to presented antigen via 
delivery of Lck to vicinity of TCR/CD3 complex. Phosphatase CD45 plays an important 
part in positive regulation of Lck activity by dephosphorylating its C-terminal negative 
regulatory tyrosine Y505. Integrin LFA-1 provides adhesive function through binding to 
ICAM ligand expressed on APCs and thus mediating T-cell:APC interaction. Last but 
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not least are co-stimulatory molecules CD28 and CTLA-4 involved in the regulation of 
T-cell activation.  
 
2.4.2.3 Proximal TCR signalling  
First seconds after TCR/MHC engagement are crucial for development of downstream 
signal response and the full activation of T-cells (Fig. 2.4B). The most proximal, 
biochemically detectable cellular event occurring after antigen recognition is the 
induction of tyrosine phosphorylation by two SFKs, Lck and Fyn. Upon activation, 
extracellular portion of CD4, the transmembrane co-receptor associated with Lck 
intracellularly, binds simultaneously with TCR to pMHCII complex and juxtaposes Lck 
to the proximity of TCR/CD3 chains. Both kinases contribute to phosphorylation of 
tyrosine residues on ITAMs within the chains of TCR/CD3 complex. Once 
phosphorylated, these motifs serve as docking sites for SH2 domain of ZAP-70 
(member of Syk family kinases). After recruitment to ITAM motifs, Lck further 
phosphorylates and thus activates ZAP-70 as well as other Protein Tyrosine Kinases 
(PTKs) of Tec family. The phosphorylation level in T-cell is rapidly increasing and 
culminates in activation of other downstream signalling proteins and pathways.  
 
2.4.3 Signal diversification and regulation module 
After their activation, ZAP 70 and Lck phosphorylate several target proteins resulting in 
diversification of regulatory signalling pathways (Fig. 2.4C). Linker for activated T-cell 
(LAT) is the primary target for ZAP-70 phosphorylation. It serves as the scaffold 
protein for recruiting additional proteins, including phospholipase C gamma (PLCγ), 
Grb-2, Gads, Cbl and PI3K via their SH2 and SH3 domains. This multimeric protein 
complex is the initiation point for activation of several signalling pathways. Critical in 
this sense is the recruitment and activation of PLCγ , Ras  and Vav signalling pathways 
resulting in the activation of NF-AT, NF-кB and AP-1 transcription factors which then 
cooperatively bind to IL-2 promoter and synergistically induce the transcription and 
production IL-2 cytokine which is required for T-cell proliferation (Monks et al., 1997; 
Nel, 2002). LAT recruitment of GADS-associated multiproten complex consisting of  
SLP-76, VAV, ITK, NCK, WASP and PAK is responsible for initiation of actin 
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remodelling and cytoskeleton rearrangement (Billadeau et al., 2007). PI3K attachment 
to LAT activates AKT kinase, which promotes cell survival via upregulation of anti-
apoptotic proteins BAD and BCL-xL. Thus, TCR activation leads to a multifaceted 
cellular response leading to global changes in gene expression and ultimately to 
cytoskeleton reorganization, proliferation and differentiation of T-cells.   
Figure 2.4 T-cell activation signalling pathways. Initiation of T-cell signalling could be 
divided into following three modules. A. The first module contains regulatory units controlling 
Lck activation. Inactive Lck in resting T-cells is in “closed” conformation which retains the 
phophorylation of negative regulatory tyrosine (Y505) at Lck C-terminal tail mediated by Csk. 
Phosphatase CD45 opposes Csk function by dephosphorylating pY505, thus enabling the 
opening of Lck structure into “primed” conformation. B. The Second module features clustering 
of Lck in the proximity of TCR/CD3 complexes upon TCR engagement. Due to induced 
clustering, Lck molecules transphophorylate each other on their activatory tyrosine (Y394) and 
achieve fully “active” state. Kinase active Lck then phosphorylate ITAM motifs of CD3 chains 
which serve as docking sites for ZAP-70 kinase which is then recruited and further activated by 
Lck phosphorylation. C. The schematics of the third module depicts the phosphorylation of 
adaptor proteins LAT and SLP-76 by active ZAP-70 and Lck resulting in diversification of 
several regulatory signalling pathways responsible for initiating changes in gene expression, 
cytoskeleton rearrangement and cell adhesion. (Taken from Acuto et al., 2008). 
A. B. C. 
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2.4.4 CD28 – important co-receptor molecule 
CD28 plays an important role in T-cell activation as it provides the secondary co-
stimulatory signal upon its interaction with members of B7 family receptors expressed 
on APC. In the absence of this signal, TCR/CD3 engagement results in T-cell anergy or 
even death. If both TCR- and CD28-mediated signals are provided, IL-2 production is 
significantly increased.  
It has been shown that CD28 proline-rich sequences can directly interact with SH3 
domain of Lck and Fyn. Binding of Lck to CD28 seems to be a necessary prerequisite 
for sustained Lck phosphorylation of activatory Y394 in the catalytic domain (Holdorf 
et al., 2002). In addition to Lck, CD28 binds also to Itk and PI3K, but a disruption of 
these interactions did not provide any obvious signalling phenotype (Nel, 2002). It is 
assumed that several, yet unknown compensatory mechanisms and cross-talks operate 
between TCR and CD28 triggered pathways.  
Recruitment of CD28 and its localization in cSMAC requires sustained TCR signalling 
and interaction with B7 ligands on APC (Sanchez-Lockhart et al., 2008). Subsequently, 
CD28 induces translocation of PKCθ to the same sub-region of IS what results in 
activation of NF-кB transcription factor (Huang et al., 2002; Yokosuka et al., 2008). 
The mechanism responsible for translocation of CD28 into IS depends on cytoskeleton 
reorganization and local accumulation of lipid rafts. Molecular machinery involved is 
veiled but one protein candidate, filamin A (FLNA), was recently discovered. FLNA is 
a cytoplasmic protein able to bind to both the cortical actin and CD28. Downregulation 
of FLNA in Jurkat T-cells results in abrogated CD28 localization into IS (Tavano et al., 
2006). 
 
2.5 Role of cytoskeleton in T-cell activation 
The proper functioning of cytoskeleton is absolutely essential for T-cell activation. 
Cellular cytoskeleton consists of three distinct systems: actin, microtubules and 
intermediate filaments. Together they regulates critical physiological processes 
including T-cell movement and cellular polarization during IS formation through 
integrin-mediated adhesion and signal sequestration (Billadeau et al., 2007; Burkhardt 
et al., 2008).  
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So far, it seems that the most important contribution comes from filamentous actin (F-
actin). Its explosive polymerization upon TCR engagement is responsible for T-cell 
polarization, the formation of IS and the establishment of Distal Pole Complex (DPC). 
In addition it supports the sequestration and/or translocation of signalling molecules into 
their interaction sites upon T-cell activation. Signalling cascade Lck-ZAP70-SLP-76-
Vav is required for this process. Ultimately, Vav activates small RHO-GTPase CDC42 
and RAC1 and they, via intermediaries, activate actin regulatory protein complex 
ARP2/3 which directly regulates actin polymerization. F-actin is also involved in the 
spatial re-localization of negative regulators during the onset of T-cell signalling into 
DPC. Actin linker proteins ezrin and moesin, which belong to ERM family, binds DPC-
associated proteins CD43 and EBP50 and they, in turn, interact with SFK negative 
regulator Phosphoprotein Associated with GEMs (PAG) (Brdickova et al., 2001). 
Moreover, as Ezrin transiently translocates to IS during the early phase of T-cell 
activation, it suggests, that it might be involved in the delivery and/or removal of a 
cargo to or from IS, respectively (Shaffer et al., 2009).  Besides actin polymerization, T-
cell activation is accompanied by the reorientation and translocation of Microtubule-
Organizing Center (MTOC) to the proximity of T-cell:APC contact zone. Reorientation 
of MTOC towards IS seems to be important as microtubules function as a tubular 
network supporting a directed secretion of transportation vehicles containing various 
lymphokines (IL-2, IL-4) or cytotoxins (perforins, granzymes) towards APC surface or 
target T-cell (Stinchcombe et al., 2006). 
 
2.6 Negative regulators of T-cell activation 
To downregulate signalling pathways controlling T-cell activation, several inhibitory 
feedback mechanisms operate to maintain an equilibrium and T-cell homeostasis (Acuto 
et al., 2008). As a good example of negative feedback mechanism serves the 
phosphorylation of PAG by kinase active Fyn which in turns leads to the recruitment of 
Csk, the main negative regulator of Fyn and Lck. (Filby et al., 2007). Furthermore, the 
surface expression of negative T-cell regulator CTLA-4 competes with CD28 co-
stimulatory receptor for B7 ligands. CTLA-4 exerts the negative regulatory function via 
its association with phosphatase SHP-2 which binds to ξ-chains of TCR and 
dephosphorylates them. A negative function has also been ascribed to protein Cbl, the 
ubiquitine E3 ligase, responsible for enhanced degradation of PTKs. Tyrosine 
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phosphatase SHP-1 participates in downregulation of T-cell activation through binding 
to receptors containing Immunnoreceptor Tyrosine-based Inhibition Motifs (ITIMs) and 
by dephosphorylating activatory pY394 of Lck. Many other proteins involved in 
downregulation of T-cell activation have been recently cloned and characterized, for 
example DOK, HPK1 and STS to list just a few (Acuto et al., 2008). 
Figure 2.5 The plasma membrane. The plasma membrane has an asymmetric composition of 
lipids in outer (sfingolipids, glycosphingolipids, phosphatidyl-choline) and inner 
(glycerophopholilids) leaflets. Proteins and lipids non-covalently associate and can form 
membrane rafts (pink). Rafts are very dynamic, sterol- and sphingolipid-enriched islands 
immobilizing glycosyl-phosphatidylinositol (GPI)-anchored proteins (purple). Subcortical actin 
and actin-binding proteins play the key role in regulation of membrane-raft dynamics interacting 
with lipids of inner leaflet (Taken form Viola and Gupta, 2007). 
 
2.7 Lipid rafts 
2.7.1 General characterisation of lipid rafts 
In 1972 Singer and Nicolson presented the “fluid mosaic” model of plasma membrane 
where phospholipids, basic building stones of membrane, exhibit a very rapid lateral 
movement along the membrane bi-layer (Singer and Nicolson, 1972). According to this 
model, lipids are distributed randomly and form liquid disordered structures (Ld). 
However, a new plasma membrane model (Fig. 2.5), acknowledging the existence of 
very small, heterogeneous clusters consisting of sphingolipids with long saturated acyl 
chains and sterols has been proposed (Simons and Ikonen, 1997). These membrane 
micro-heterogeneities, forming liquid-ordered structures (Lo) are called lipid rafts (LR) 
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or Detergent Resistant membrane Microdomains (DRMs). “Lipid raft hypothesis” 
defines LR as lipid clusters insoluble in mild non-ionic detergents at low temperature 
(for example Triton X-100 or Brij-58 at 4°C) (Simons and Toomre, 2000). Even though 
this definition is operational (definition of LR is based on a procedure used for their 
isolation) (Methods section 3.12), there is a general consensus among “raftologist” 
(scientists studying LR) that LR concentrate and co-localize proteins and protein 
complexes involved in the process of T-cell activation. Despite the fact that in the last 
few years existence of LR has been quite well documented (Viola and Gupta, 2007), 
their functional and physiological importance still awaits its full justification (Munro, 
2003; Shaw, 2006). Important questions concerning their formation, lifetime, size, 
dynamics, composition, turnover, movement and importance remain to be answered.  
 
2.7.2 LR in T-cell activation 
Recently published studies suggest that LR regulate spatial segregation of signalling 
molecules on the plasma membrane before and shortly after T-cell activation (Manes 
and Viola, 2006; Rodgers et al., 2005; Viola and Gupta, 2007). During lymphocytes 
migration from blood stream to their target destination, T-cells exhibit morphological 
and functional asymmetry changes called polarization. This process involves a 
reorganization of subcortical actin cytoskeleton and a polarized assembly of LR. The 
formation of two cellular poles – leading edge at the cell front and uropod at the rear, 
correlates with distinct distribution of LR subtypes: U-rafts at the uropod, characterized 
as GM1-containing rafts and GM3-containing L-rafts at the leading edge. Differences in 
composition of L- and U-rafts could signify their role in the recruitment and segregation 
of two sets of proteins exhibiting specific and mutually incompatible functions. Usually 
proteins involved in actin reorganization are targeted to the leading edge and include 
chemotactic receptors and CD28.  Receptors and proteins playing a role in cell adhesion 
(ICAM1-3, CD43, CD44, ERM) segregate preferentially to the uropod.  
During formation of IS, small LR microclusters on both sides of polarized cell coalesce 
into one larger macrodomain, thus targeting and concentrating signalling proteins to IS 
or to DPC (Rodgers et al., 2005). The mechanisms underpinning regulated 
compartmentalization of signalling elements are not known, nevertheless available data 
strongly suggest that raft dynamics depends mainly on F-actin rearrangements. It is 
25 
 
supported by interactions of actin with several LR-residing molecules thus mediating 
actin attachment to LR. For example, as mentioned previously, FLNA cross-links actin 
filaments to generate and sustain sub-cortical actin cytoskeleton and it simultaneously 
interacts with the co-stimulatory molecule CD28 localized in LR (Tavano et al., 2006). 
Another example is CD28 engagement-induced activation of Vav-dependent actin 
polymerization pathway. Furthermore, ERM proteins are also involved in interaction 
with actin and signalling molecules associated with LR like PAG (Brdickova et al., 
2001). All together, these data point to the essential importance of LR and cytoskeleton 
cooperation in regulation of T-cell migration and activation.  
Propensity of proteins to distribute to LR is largely dictated by the structure and type of 
their transmembrane domain and/or posttranscriptional modifications. As an example of 
relevant LR-targeting modifications are SFKs Lck and Fyn (double acylation of N-
terminal segment) and a cysteine palmitoylation of adaptors LAT and PAG. By the 
same token, GPI anchor also target proteins to LR due to its resemblance to 
sphingolipids. It is assumed that an enrichment of other proteins, like TCR and B-cell 
receptor, in LR is induced upon activaton of T-cells by virtue of their complexation or 
clustering with LR-targeted proteins.  
Recently a new model of proximal T-cell activation demonstrating an involvement of 
LR in this process has been proposed (Filipp et al., 2004; Filipp et al., 2003) and is 
described in following section.  
 
2.8 Lck-dependant Fyn activation model 
Lck-dependent Fyn activation model, describing non-redundant and interdependent 
functions of two Src family tyrosine kinases Lck and Fyn that predicate the generation 
of the most proximal signals emanating from the antigen receptor complex in T-cells 
has been described (Fig. 2.6). In this model, LR not only function to segregate Lck and 
Fyn but also couple the process of membrane translocation with temporal and spatial 
regulation of their enzymatic activities. Specifically, in primary resting T-cells, 75-95% 
of Lck resides outside LR and is physically segregated from more than 98% of Fyn 
residing in LR. Co-aggregation of TCR and CD4 results in Lck activation within 
seconds outside LR, followed by its translocation into LR and the activation of co-
localized Fyn. The  kinase activity of Fyn was observed to peak at 30 to 90 seconds 
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after TCR/CD4 co-aggregation (Filipp et al., 2003). These results define Lck as a 
mobile signalling element and underscore the importance of targeting its kinase activity 
in delivery of function (Filipp et al., 2004; Filipp et al., 2003). 
Figure 2.6 Model of Lck dependent Fyn activation through translocation of Lck kinase 
into LR. This model is based on the fact that in resting naive CD4
+
 T-cells 75-95% of Lck 
resides outside of LR whereas more than 98% of Fyn is in LR (Filipp et al., 2003) A. Upon 
TCR engagement, dephosphorylation of pY505 by CD45 phosphatase and transphosphorylation 
of Y394 activates Lck. Fully active Lck initiates ITAM phosphorylation and recruitment of 
ZAP-70 kinase to CD3 complexes.  At same time, Fyn is localized in LR, where its activity is 
negatively regulated by PAG/Csk/PEP feedback mechanism which is at least partly controlled 
by PKA. B. During the first 90 seconds after T-cell activation the entire TCR/CD3/Lck complex 
somehow translocates into LR, where it inhibits the function of PAG/Csk/PEP complex and 
subsequently activates Fyn.  While the mechanism of translocation remains largely unknown, an 
involvement of cytoskeletal network is expected. (Taken from Filipp and Julius, 2004). 
A. 
B. 
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The subsequent structure-function analysis towards characterizing the mechanism 
supporting Lck partitioning to LR and its capacity to activate co-localized Fyn  showed 
that only LR-associated, kinase active Y505F-Lck reciprocally co-immunoprecipitates 
with and activates Fyn (Filipp et al., 2008). Mutational analyses revealed a profound 
reduction in the formation of Lck-Fyn complexes, and Fyn activation, using kinase 
domain mutants K273R and Y394F of Y505F-Lck, both of which have profoundly 
compromised kinase activity. The only kinase active Lck mutants tested that revealed 
impaired physical and enzymatic engagement with Fyn were those involving truncation 
of the C-terminal sequence YQPQP. Remarkably, sequential truncation of YQPQP 
resulted in an increasing reduction of kinase active Lck partitioning to LR, in both 
fibroblasts and T-cells. This in turn correlated with an ablation of the capacity of these 
truncates to enhance TCR mediated IL-2 production. Thus, Lck-dependent Fyn 
activation is predicated by proximity-mediated transphosphorylation of the Fyn kinase 
domain; and targeting kinase active Lck to LR is dependent on the c-terminal sequence 
QPQP (Filipp et al., 2008). 
 
2.9 Identification of candidate proteins involved in translocation of Lck to LR 
One prediction derived from the model of Lck-dependent Fyn activation is that the 
critical regulatory step in activation of Fyn kinase is the translocation of kinase active 
Lck to LR. However, there is a paucity of information in regard to the mechanism and 
the molecular machinery underpinning this process.  
As described in the previous section, the truncation of the last five C-terminal residues 
of kinase active Lck ( FQPQP) profoundly reduced its partitioning to LR. This suggests 
that the C-terminal tail of Lck functions as LR targeting sequence. Our working 
hypothesis is that the FQPQP sequence targets Lck to protein(s) of the cytoskeletal 
network and supports their phosphorylation. This, in turn, initiates an early and very 
rapid cytoskeletal network reorganization culminating in the re-distribution of Lck to 
LR. Consistent with this hypothesis is the inability of constitutively active FQPQP-
Lck to phosphorylate several low molecular weight proteins detected in the presence of 
full length constitutive active Y505F-Lck, thus identifying these phosphoproteins as 
candidates in targeting Lck to LR (Fig. 2.7A). Comparative 2-dimensional (2D) gel 
analyses followed by immunoblotting with phosphotyrosine specific mAb 4G10 
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identified several differentially phosphorylated protein spots (Fig. 2.7B). Some of them 
have been isolated and are currently being analysed. Closer characterization of one of 
them, identified as Receptor for Activated C Kinase 1 (RACK1) is the subject of this 
investigation.  
Figure 2.7 Identification of proteins involved in the translocation of Lck kinase into LR.  
A. The C-terminal sequence (YQPQP) functions as a lipid raft targeting sequence of Lck. 
Comparative analysis of tyrosine-phosphorylated cellular proteins derived from lysates of 3T3 
cells expressing either the constitutive active Y505F-Lck (505 Lck) or the constitutive active 
∆FQPQP C-terminal truncate Lck (FQPQP Lck), revealed a failure of FQPQP-Lck to 
phosphorylate several, mostly low-molecular weight proteins (red rectangle). B. To increase the 
resolution of proteins of interest shown in A. (red rectangle), a comparative 2D-gel 
electrophoresis was implied. Several spots displaying significant differences in phosphotyrosine 
content (demarcated by red lines) were isolated, subjected to MS-MALDI analysis and 
subsequently identified (Filipp et al., unpublished data). Gels shown in A. and B. were blotted 
with anti-phosphotyrosine-specific antibody (4G10). 
 
A. B. 
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2.10 RACK1 – Receptor for activated C kinase 1 
A group of functionally homologous proteins, named RACKs, able to bind activated 
PKCs  were first characterized in 1991 (Mochly-Rosen et al., 1991). Tree years later,  
RACK1 was cloned from rat brain cDNA expression library and characterized as 
homolog of the β-subunit of trimeric G proteins and also as interaction partner for 
PKCβII isoform (Ron et al., 1994). Then, additional two RACK-related proteins were 
identified: RACK2, which binds PKCε (Csukai et al., 1997) and PRKCBP1, the binding 
partner for PKCβI (Fossey et al., 2000). RACKs do not posses any catalytic activity and 
are believed to function as the scaffolding and/or adaptor proteins involved in various 
signalling processes. RACK1 and RACK2 are members of a very ancient protein 
superfamily, called WD proteins, which consist of several “WD40 repeats”, sequences 
ending with Try-Asp dipeptide (Neer et al., 1994).  
Figure 2.8 The protein structure of RACK1. RACK1 contains seven WD40 domains and 
each unit consists of three β-sheets and two α-turns. Based on crystallographic data of 
homologous WD40 motif containing proteins, the tertiary structure of RACK1 protein was 
deduced using the software program PyMol (Sondek et al., 1996; Wall et al., 1995) and 
(http://pymol.org/). RACK1 forms seven-blade propeller-like structure where each WD40 
domain corresponds to one blade.  
 
RACK1 is 36k Da protein, containing seven WD40 repeats (Fig. 2.8) (Steele et al., 
2001). It is evolutionary highly conserved in a wide range of eukaryotes including 
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plants, fungi and yeast, suggesting that biological function of RACK1 was well 
enrooted before evolutionary split into plant and animal kingdoms (Neer et al., 1994). 
RACK1 is express in various tissues in mammals, suggesting its important 
physiological role in the most cell types. In addition, WD40 domains with the propeller 
structure, provides RACK1 with multiple binding sites allowing formation of distinct 
protein-protein complexes what in turns predispose RACK1 to be involved in a broad 
range of cellular processes. 
 
2.10.1 RACK1 binding partners 
Activated Protein Kinase C (PKC) was characterized as the first binding partner of 
RACK1 (Mochly-Rosen et al., 1991). Notably, as only the activated form of PKC was 
able to interact with RACK1, it was suggested that RACK1 could serve as a 
transportation and delivery vehicle for targeting its activated binding partners to the 
specific intracellular compartments where they execute their effector function (Ron et 
al., 1994). 
 This is certainly the case for PKCβII, a serine/threonine kinase, whose activity depends 
on phospholipids, calcium and mainly on DAG. Upon activation by phorbol esters (e.g. 
phorbol 12-myristate 13-acetate - PMA) or hormones, an elevated concentration of 
DAG induces RACK1-PKCβII co-localization which predicates their coordinated 
translocation and redistribution to a distinct subcellular compartment (Ron et al., 1999) 
(Figure 2.9A). While mechanisms regulating these dynamic processes are still obscure, 
multiple protein binding capacity of RACK1‟s seven WD40 domains most likely 
contribute to this processes. In this context, several interacting partners, including 
integrins (Liliental and Chang, 1998), pleckstrin homology (PH) domain-containing 
spectrin and dynamin-1 (Rodriguez et al., 1999), the cytoskeletal linker protein plectins 
(Osmanagic-Myers and Wiche, 2004) as well as other proteins (McCahill et al., 2002; 
Schechtman and Mochly-Rosen, 2001; Sklan et al., 2006) have been characterized and 
the mechanistic model of their potential contribution suggested.  
For example, proteins which PH domain binds to membrane phospholipids are also 
substrates for PKCβII (pleckstrin, dynamin-1). Thus, RACK1, associated with kinase 
active PKCβII and anchored by these proteins to the plasma membrane functions as an 
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adaptor protein allowing its interacting kinase to phopshorylate its substrates and 
activate them. Similarly, β-integrins which play an important role in cell adhesion, and 
are involved in cytoskeleton rearrangement can also be phosphorylated by activated 
PKC. Thus, RACK1 may also regulate cell adhesion by linking PKC and β-integrins 
together (Cox et al., 2003; Liliental and Chang, 1998). Consistent with this data is the 
role of RACK1 in activation of adhesion-induced MAPK/ERK pathway. In this 
scenario RACK1 acts as a scaffold protein localizing MAPK/ERK cascade to focal 
adhesion sites (Vomastek et al., 2007).  
Figure 2.9 Time dependent co-localization and movement of RACK1 with PKCβII and Src 
upon cell treatment with NPA and PMA respectively. A. CHO/D2L cells were treated with 
trihydroxy-N-propyl-noraporphine hydrobromid (NPA) and probed with anti-PKCβII (red) and 
anti-RACK1 (green). The activation induces co-localization of both proteins (see 1 and 2 min. 
time points) prior to their co-redistribution into a restricted subcellular compartment (5 min time 
point) (Taken from Ron et al., 1999). B. NIH3T3 cells overexpressing Src kinase were treated 
with PMA for the time indicated and immunostained for Src (green) and RACK1 (red). 10 
minutes after PMA treatment Src and RACK1 were found translocated to the plasma membrane 
where they co-localized. (Taken from Changet al., 2001). 
 
A. 
B. 
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Plectin-mediated interaction of RACK1 with cytoskeleton was also reported 
(Osmanagic-Myers and Wiche, 2004). Plectin is a cytoskeletal linker protein able to 
dynamically interact with all three major cytoskeletal elements (actin, microtubules and 
intermediate filaments) and with components of cell adhesion machinery (Svitkina et 
al., 1996; Wiche, 1998). Importantly, RACK1-plectin-cytoskeleton interactions were 
observed only after PKC activation-induced translocation of RACK1 to plasma 
membrane, where co-localization of these proteins was detected.  
Importantly, as WD40 domains can form hetorodimers, potential number of interacting 
proteins containing this domain can be quite large. For example as previously described, 
RACK1 is the homolog of β-subunit of heterotrimeric G proteins. G proteins trigger 
various extracellular signal-induced signalling pathways emanating from G-protein 
coupled receptors (Hamm, 1998). Upon activation they break up into two parts – α and 
βγ subunits. After its release from the trimeric complex, β-subunit containing WD40 
domains mediates the recruitment of RACK1 to plasma membrane (Chen et al., 2004b). 
Gβγ-RACK1 complex then inhibits the activation of PLCβII and adenylyl cyclase II 
(Chen et al., 2004a).  
 
2.10.2 RACK1-Src interaction 
Src tyrosine kinase, involved in regulation of cell growth and differentiation, was also 
identified as RACK1 binding partner (Chang et al., 1998). It belongs to SFK 
superfamily and exhibit the same domain structures as described for Lck (Fig. 2.2). 
Moreover, using in vitro binding studies utilizing glutathione S-transferase (GST) 
fusion proteins, it has been shown that RACK1 is also able to interact with two other 
SFKs - Lck and Fyn (Chang et al., 1998). The interaction between RACK1 and SFKs is 
mediated by SH2 domains binding to the phosphotyrosines in sixth WD40 domain of 
RACK1 (Chang et al., 2001). Mutational analyses of HA-tagged RACK1 expressed in 
NIH3T3 cell line demonstrated importance of pY246 in sixth WD40 repeat for Src 
binding. In addition, both Y246 and Y228 can be phosphorylated by Src, suggesting 
that RACK1 as a substrate for Src (Chang et al., 2002). Tyrosine phosphatase PTPµ, has 
been also reported to bind to RACK1, but the physiological significance of this 
interaction remains to be elucidated (Mourton et al., 2001).  
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Interestingly, HA-RACK1 overexpression inhibits the activity of Src kinase and 
suppresses the growth of NIH3T3 cells by prolonging G0/G1 cell cycle phase (Chang et 
al., 1998). This is consistent with the demonstration that RACK1 overexpression 
regulates G1/S progression by influencing cell cycle regulators in G1 checkpoint 
(Mamidipudi et al., 2004). RACK1 downregulation via siRNA overcomes this block. 
Mechanism underlying this regulation relates to RACK1-mediated Src downregulation 
and interference with phosphorylation of Src substrates required for cell cycling 
(Mamidipudi et al., 2007; Miller et al., 2004). Thus, RACK1 mediated suppression of 
oncogenic Src shows critical function of this kinase in cell cycle arrest and points to the 
possibility to use this information for designing new methods for cancer treatment.  
Besides above described interactions and mechanisms involving RACK1, several other 
interacting partners for RACK1 were described. Namely, PLCγ – functioning upstream 
of PKC signalling pathway;  rasGAPs – responsible for the activation of small GTPases 
involved in various cellular processes including actin rearrangement; PDE4D5 – 
regulator of  cAMP activation pathway to list just a few [reviewed in (McCahill et al., 
2002; Schechtman and Mochly-Rosen, 2001)].  
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3 Materials and Methods 
3.1 Materials 
3.1.1 Mice 
Three mice strains of C57BL/6 genetic background, six to eight week old males, were 
used: WT strain, OTII transgenic mice with T cell receptor transgene specific for OVA 
peptide (gift from Prof. Hořejší laboratory) (Barnden et al., 1998) and MHC class II–
EGFP Knock-in mice (Boes et al., 2002). They were housed in pathogen-free animal 
facility at Institute of Molecular Genetics (Prague, Czech Republic). 
3.1.2 Cell lines, cell preparation and culture  
NIH3T3 fibroblast cell line, Lck infectants and HEK293T cell line were maintained in 
Iscove‟s Modified Dulbecco‟s Medium (IMDM) (Gibco) supplemented with 10% of 
inactivated fetal calf serum (FCS) and 100 Units of penicillin / 10µg streptomycin 
antibiotics (Sigma) per 1 ml of media. 
Figure 3.1 High enrichment efficiency of MACS CD4
+
 T-cell separation. CD4
+
 T-cells prior 
and after MACS-enrichment were stained with APC-conjugated anti-TCR (APC) and FITC-
conjugated anti-CD4 and analyzed by FACS. Prior MACS, approximately 30% of total cells 
isolated from lymph nodes are CD4
+
 T-cells (left panel). After MACS the purity of isolated 
CD4
+
 T-cells increased up to 95% (right panel). Representative dot plots are selected from 
several independent experiments 
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Primary CD4
+
 T-cells were obtained from axillary, brachial, inguinal and superficial 
cervical lymph nodes of 6-8 week old C57BL/6 mice males. Cell suspension was 
washed, counted and highly enriched CD4
+
 T-cell were obtained by using MACS T-cell 
separation kit according to manufacturer‟s recommendation protocol (Milteney Biotech) 
(Fig. 3.1).  
Bone marrow derived dendritic cells (BMDC) and macrophages (BMMF) from OTII 
transgenic mice were isolated from mice femur and tibia cavities. The cells were 
cultured for 6 days in RPMI medium supplemented with GM-CSF-containing 
supernatant produced by LUTZ cell line (final concentration was adjusted to 4%). After 
three days of cultivation, one half of the media was replenished and on day 6, the cells 
were pulsed with OVA antigen. 
3.1.3 Antibodies 
All antibodies used are listed in Table 1. 
Name of Ab 
Source of 
Ab origin 
Conjugate/purified Source of Ab 
Primary Antibodies    
Anti-Lck rabbit Polyclonal Gift from Prof. Hořejší 
laboratory Anti-Fyn rabbit Polyclonal 
Anti-RACK1 mouse Purified Santa Cruz 
Anti-RACK1 – N terminal rabbit Polyclonal Sigma 
Anti-αTubulin rabbit Polyclonal GeneTex 
Anti-Vimentin (VI-10) mouse AlexaFluor 488 Exbio 
RHPM  Rhodamin-Phalloidin Gift from Dr. Dráber 
Anti-TCRCβ (H57) hamster Biotin eBioscience 
Anti-CD4 (GK1.5) rat Biotin eBioscience 
4G10 (pY) mouse  Gift from Prof. Hořejší 
laboratory 12CA5 (HA) mouse Purified 
Secondary Antibodies - IHC    
Alexa Fluor® 488 goat anti-rabbit IgG   AlexaFluor 488 Invitrogen 
Alexa Fluor® 555 goat anti-mouse IgG)  AlexaFluor 555 Invitrogen 
Alexa Fluor® 647 goat anti-rabbit IgG   AlexaFluor 647 Invitrogen 
Secondary Antibodies - WB    
GαM HRP  HRP Biorad 
GαM HRP True Blot  HRP eBioscience 
GαRa HRP  HRP Biorad 
Protein A HRP  HRP Biorad 
Cholera Toxin B subunit HRP   HRP Sigma 
    
Table 1.  Primary and secondary antibodies and their specifications 
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3.1.4 cDNA vectors 
Lck constructs were inserted into the murine stem cell virus (MSCV)-based internal 
ribosome entry site (IRES)-enhanced green fluorescent protein virus MigR1 (Pui et al., 
1999), permitting the concurrent expression of a given gene and EGFP. Generation of 
retrovirus packaging cell lines and retrovirus stock as well as infection of NIH3T3 were 
performed as outlined elsewhere (Davidson et al., 1994; Leung et al., 1999).  
 
3.2 Bacteria plasmid transformation 
TOPO10 chemo-competent bacteria (E. coli, Invitrogen) were used for plasmid 
transformation. 1µg of plasmid DNA was added to 50µl-aliquot of bacteria, incubated 
for 20 minutes on ice and then subjected to heat shock in 42°C waterbath for 2 minutes. 
Sample was immediately returned on ice. 200µl of S.O.C. media (Invitrogen) was added 
and the bacteria was allowed to recover by incubation in 37°C incubator. After 30 
minutes bacteria was plated out onto agar plates supplemented with appropriate 
antibiotic and incubated O/N in 37°C. 
 
3.3 Plasmid isolation 
Plasmids from transformed bacteria were isolated by Zyppy™ Plasmid Miniprep Kit II 
(Zymo research) according manufacture‟s protocol for low scale bacterial cultures (3 
ml) and by Jetstar Plasmid Purification Midi Kit (Gemomed) for medium scale amounts 
(50 ml).  
 
3.4 Flow cytometry (FACS) and cell sorting 
FACS analysis was performed using Calibur or LSRII instruments, for sorting purposes 
we used FACSVantage SE instrument. Data were analysed using FlowJo statistic 
software. Cells were stained with direcly conjugated antibodies or sequentially, with 
primary then secondary Abs in appropriate combinations. The cells were washed and 
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analysed. Dead cell were excluded from analysis by addition of vital dye propidium 
iodide or Hoechst 33258. 
 
3.5 Retroviral Cell infection 
Transfection of HEK293 was conducted with Lipofectamine™ LTX and PLUS™ 
reagent (Invitrogen) and manufacture‟s protocol was followed with some small 
modifications. Briefly, 0,2x10
6 
of HEK293T cells were seeded into a 6 well plate and 
let to adhere overnight (O/N). On the second day, culture medium was replaced by Opti-
MEM® I (Gibco) supplemented with 10% FCS without antibiotics. Transfection 
complexes were prepared by mixing 3µg of plasmid DNA (this consisted of 1µg 
plasmid DNA encoding Env gene, 1µ plasmid DNA encoding Gag and Pol retroviral 
genes, and finally 1µg of plasmid DNA coding the protein of interest) diluted in 500µl 
of Opti-MEM® I medium with 3µl of PLUS™ reagent.  The mixture was incubated for 
5 minutes at room temperature and 7,5µl Lipofectamine™ LTX reagent was added and 
incubating for 30 minutes at room temperature. Formed DNA complexes were then 
added dropwise to adhered HEK293T cells. After 6 hours of incubation the medium 
was exchanged for IMDM + 10% FCS and cells were incubated at 37°C for next 24-48 
hours. In parallel, 0,2 x 10
6 
NIH3T3 cells were seeded in 6-well plate and cultured O/N. 
Next day, in 24 hours post-transfection time point, virus particles-containing 
supernatant from HEK293T cells was transferred to NIH3T3 cells and polybrene 
reagent (Sigma) was added to a final concentration of 8µg/ml. Additional 2ml of media 
was added to HEK293T cells and newly produced viral particles were harvested and 
used for a second round of NIH3T3 infection after 24 hours. 48 hours after infection, 
the transfection efficiency was analysed by flow cytometry and positive clones were 
sorted out by cell FACS-sorting. 
 
3.6 Transient lipofectamin transfection 
0,6 x 10
6 
of NIH3T3 cells were seeded in 6-well plate to adhere O/N and were used for 
transfection assay using PLUS™ and Lipofectamine™ LTX reagents as described 
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above (chapter 3.6.) After 24 hours cells were harvested and used for 
immunoprecipitation. 
 
3.7 SDS PAGE gel electrophoresis and Western blotting 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and Western 
blotting (WB) followed standard protocols described in Sambrook and Russel, 2001 
(Vol. 3, App. 8, chapters 8.40 - 8.55). Briefly, samples were loaded into polyacrylamide 
gels (9% to 12,5%) and run in SDS running buffer (25mM Tris, 192mM glycin, 0,1% 
(w/v) SDS). Resolved proteins were transferred onto PVDF membrane (BioRad) by 
“wet” blotting in methanol transfer buffer (20mM Tris, 156mM Glycine, 20% MeOH). 
Membranes were washed in TBS-T buffer (20mM Tris-HCl pH 7.5, 150mM NaCl, 
0,05% Tween) and blocked for 1 hour in 5% non-fat milk diluted in TBS-T or in 3% 
gelatine at 37°C (phospho blots). Blots were then incubated for 1 hour with primary 
antibodies diluted in blocking buffer (5% milk or 1% gelatine, respectively) followed by 
5 washes in TBS-T (10 minutes each) and incubation with secondary antibodies 
conjugated to horseradish peroxidase (HRP). After 5washes (10 minutes each), blots 
were developed by incubation with the ECL substrate (Pierce) for 1 minute. 
Chemiluminiscent signals were visualized by exposure to X-ray films. 
 
3.8 Immunoprecipitation 
For immunoprecipitation purposes, antibodies directed against the protein of interest 
were bounded to Protein G Agarose beads (10μl bed volume/sample) (Roche) by 
incubation for 4 hours at 4°C. NIH3T3 cells or primary CD4+ T-cell were lysed in 
hypotonic TNE lysis buffer (50mM Tris-HCl pH 8.0, 20mM EDTA pH 8.0, 1% NP-40, 
protease complete inhibitor cocktail (Roche), 20mM NaF, 0.2mM orthovandate-
natrium), incubated on ice for 30 minutes and centrifuged at 4°C at 12000g for 10 
minutes. Supernatant was transferred to antibody-pre-coated beads and incubated 
overnight at 4°C on rotation wheel. Next day beads were collected, washed five times 
with TNE buffer without protease inhibitors, boiled in reducing sample buffer at 100°C 
for 5-10 minutes and used for SDS-PAGE analysis 
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3.9 Antibody-mediated TCR/CD4 co-aggregation of primary CD4+ T cells 
Freshly isolated and highly enriched (~95% purity) naïve CD4+ T-cell (AutoMACS T-
cell separation kit, Miltenyi Biotec) were incubated with the mixture of biotin-
conjugated antibodies (purchased from eBioscience) directed against TCR (H57 at  
1 µg/ml) and anti-CD4 (GK1.5 at 0.3µg/ml) in 500µl of PBS for 30 minutes at 4°C. The 
cells were washes twice with cold PBS+3%FCS and then resuspended in 20 µl of PBS 
per sample. The cells were then pre-warmed for 1 minute in 37°C waterbath. TCR/CD4 
co-aggregation was achieved by addition of streptavidin (Sigma) to the final 
concentration 50µg/ml, shortly vortexed and incubated at 37°C for indicated time. 
Activation was stopped by adding either ice-cold lysis buffer (immunoprecipitation), 
fixative (PFA) (microscopy) or loading sample buffer for (WB).  
 
3.10 Formation of APC-CD4+T-cell conjugates 
Preparation of conjugates for microscopic analysis of immunological synapse formation 
in vitro has been previously described (Lee et al., 2002). Briefly, BMDC and BMMF 
were prepared in parallel as described above (Methods section 3.1.2). Cells were then 
pulsed with OVA323-339 peptide for two hours and TCR-transgenic CD4
+
 primary T-cells 
isolated from OTII mice were admixed to APCs at 3:1 ratio. Formation of APC-T-cell 
conjugates was achieved by short spinning. Conjugates were incubated in serum-free 
IMDM medium at 37°C. The cells were fixed by 4% PFA for 15 minutes, stained with 
anti-RACK1 and anti-Lck directed Abs and used for the confocal microscopy analysis.  
 
3.11 Gel filtration 
Method is based on the previously described protocol (Cinek and Horejsi, 1992). 
Briefly, 5ml pipette tip closed with a small piece of glass wool was used as the column. 
It was filled with 2ml bed volume of Sepharose 4B beads (Sigma-Aldrich) and then 
equilibrated with two column volumes of cell lysis buffer. The cells were lysed in 
TKM-Brij58 lysis buffer (50mM Tris-HCl pH 8.0, 25mM KCl, 5mM MgCl2, 1mM 
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EDTA pH 8.0, 0.5% Brij-58, protease complete inhibitor cocktail (Roche), 20mM NaF, 
0.2mM orthovandatenatrium) for 30 minutes at 4°C and spun down for 1 minute at 
800xg at 4°C. Supernatant in total volume of 1/10 of stationary bead volume (200 µl), 
was loaded on the top of the column and eluted with addition of cell lysis buffer. Of 
note, it took approximately 5 minutes to collect 1 fraction (200 µl) of the eluate. Totally 
12 fractions were harvested. All steps were performed at 4°C. Figure 3.2 illustrates the 
elution profile of Lck in a typical experiment. WB analysis using antibody directed 
against the protein of choice was used to reveal its elution profile. Approximate 
molecular size marker for these fractions is indicated in Fig 4.10A.  
Figure 3.2 Lck fractionation by gel filtration.  Cell lysates from 3T3-LckY505F infectants 
were fractionated according the procedure described in this section and probed with anti-Lck. 
 
3.12 RAFT isolation 
Isolation of lipid raft is based on their insolubility in mild non-ionic detergents and 
subsequent fractionation by ultracentrifugation in sucrose gradient where they float to 
the top fractions (Filipp et al., 2004). We used this method to assess LR distribution of 
proteins of interest present in fractions obtained by gel filtration. Pooled fractions 
(Fig.4.10A) were mixed 1:1 with 80% sucrose, loaded to the bottom of 5ml 
ultracentrifuge tube and successively overlayed with 4.3 ml of 36% and 0.2 ml 5% 
sucrose (Figure 3.3). Samples were centrifuged for 14-16 hours at 250000xg at 4°C. 
Ten fractions of 500µl volume were carefully collected from each tube. Usually, LR are 
enriched in top fractions (#1-3), while the bottom fractions (#8-10) contain soluble 
proteins or protein complexes. 
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Figure 3.3 Isolation of lipid rafts by sucrose gradient floatation asssay. As lipid rafts float to 
the top of the gradient, their enrichment in top fractions is verified by binding of LR surrogate 
marker, ganglioside GM1, to cholera toxin B-subunit by WB analysis. WB analysis is also used 
to reveal the association of the protein of interest in regard to its distribution to LR.  
  
3.13 Immunofluorescence microscopy 
Immunofluorescence is used to visualize the localization and distribution of protein of 
interest within the cells. Visualization is achieved by binding of fluorochrome-
conjugated antibodies or other substances which can bind to the protein of interest with 
high specificity and sensitivity. Protocol used for this study was adopted from the cell 
signalling website (www.cellsignal.com) with some modifications. Briefly, 3x10
4 
NIH3T3 cells were seeded on glass coverslips and let to adhere O/N. Next day the cells 
were washed and fixed for 15 minutes in 4% PFA. CD4
+
 T-cells, upon their 
activativation, were immediately fixed in 4% PFA for 15 minutes and then places on 
coverslips by cytospin centrifugation (Hettich). Then, the following procedure was 
implied for all cell types. After PFA fixations, the cells were washed three times with 
PBS and permeabilized with ice-cold methanol for 10 minutes in -20°C (methanol step 
had to be omitted when phalloidine was used to stain actin cytoskeleton). The cells were 
blocked for one hour with PBS containing 0,3% Triton X-100 (PBT) with addition of  
2,5% FCS  and 2,5% BSA and then incubated with primary antibody diluted in PBT for 
one hour. Samples were washes 3 times in PBS (5 minutes each) and then incubated 
with secondary antibody for one hour. After 3 PBS washes, the coverslips were 
mounted using Vectashield containing DAPI (Vector). To avoid undesirable slippage, 
coverslips were fixed to glass by colourless nail-polish. Samples were analyzed by 
confocal microscopy (Leica DMI6000 with TCS SP5 AOBS Tandem) with HCX PL 
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APO 40x/1,25‐0,75 Oil CS UV and HCX PL APO 63x/1,40‐0,60 Oil, Lbd Blue CS 
objectives. A statistical analysis was done with LAS AF software program.  
 
3.14 RNA isolation and RT-PCR 
Reverse Transcription Polymerase chain reaction (RT-PCR) is a method where 
transcription of RNA to cDNA is followed by cDNA amplification. It is used for 
expression profiling or assessment of gene expression in a given sample.  
Total RNA isolated from 0.5x10
6
 primary CD4
+
 T-cells was isolated by QIAGEN 
RNeasy
®
 Plus Microkit (Qiagen) according to manufacturer‟s protocol. Reverse 
transcriptase (Superscript II, Invitrogen) was used to convert RNA to cDNA in three 
steps by successively adding reaction mixtures to the RNA template as highlighted 
below.  
 
Step 1.  Step 2.  Step 3.   
 hexamers - 1μl  RT buffer - 4μl    
 dNTP - 1μl  DTT - 2μl    
 RNA - x μl (1μg)  RNAout - 1μl    
 H2O to total 12μl  H2O - 0,5μl  RT-SuperscriptII - 0,5μl 
Time/°C 5 min / 65°C  2min / 25°C  10 min / 25°C  
     60 min / 42°C  
 
Retrieved cDNA was amplified by XP cycler instrument using the reaction mixture 
described below. Amplification conditions are also outlined.  
dNTP 0,2 μl       Cycler program: 
Taq Pol. Buffer 2 μl        
Forward primer 1 μl       temperature time  
Reverse primer 1 μl       94°C 120s  
Taq polymerase 1 μl       94°C 30s 36 
cDNA (sample) 1 μl       54°C 30s cycles 
H2O 13,8 μl       72°C 60s  
Total volume 20 μl          
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Table 2: List of Used Primers. Primers were designed by Roche Universal Probe 
Library (ProbeFinder version 2.44 - https://www.roche-applied-science.com/sis 
/rtpcr/upl/index.jsp) 
 
3.15 Agarose gel electrophoresis 
DNA samples were mixed with sample loading buffer containing crystal violet dye and 
loaded onto 0,5–2% agarose gels with ethidium bromide (1μg/ml). DNA was run in 
TBE buffer and resolved by applying a constant voltage. DNA Ladder Mix GeneRuler  
(Fermentas) was used as the standard molecular weight marker. 
 
  
gene Forward primer Reverse primer 
RACK1 tctgcaagtacacggtccag gagacgatgatagggttgctg 
MORG-1 ccggtgcaaacactagatga taggtcatagcgcctcacg 
EED aaattccacccacgagacc ggatattccataaccgtaaagca 
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4 Results 
4.1 General considerations 
As described in the section 2.8.1, RACK1 was identified in our screen as a candidate 
phosphoprotein involved in the regulation of Lck translocation into LR. We have 
considered RACK1 as a good match for this role for the following four reasons:  
(i) capacity of RACK1 to interact with multiple binding partners (McCahill et al., 2002) 
suggesting that this protein can form heteromeric protein complexes; (ii) RACK1 is 
directly involved in the process of intracellular redistribution of PKC kinases during cell 
activation (Ron et al., 1999) giving a precedence for its active participation in 
membrane translocation events; (iii) RACK1 is a physiological substrate for Src kinase 
with which it can interact through Src-SH2 domain (Chang et al., 2001); and lastly  
(iv) RACK1 affects the kinase activity of Lck in vitro (Chang et al., 1998) suggesting a 
physiological interplay between these two molecules.  
Our initial goal was to verify whether Lck is able to form complexes with RACK1 in 
Lck-C-terminal-dependent fashion and thus confirm results from our original screening 
strategy (chapter 2.9). Towards this end, NIH3T3 fibroblast cell line co-expressing 
defined variants of Lck together with an endogenous or ectopically expressed RACK1 
protein were used for co-immunoprecipitation experiments.  
 
4.2 Preparation of NIH3T3 Lck mutants 
First, NIH3T3 cells (3T3) expressing the wild type Lck (WT), the constitutively active 
Y50F-Lck, the kinase inactive Y394F-Lck, Lck variants with inactivating single point 
mutation in either SH2 (R154K) or SH3 (W97K) domain introduced on Y505F-Lck 
template and the C-terminal truncate of the last 11 amino acid residues ( C11) were 
prepared as previously described (Filipp et al, 2008) (Fig. 4.1A). Mutated Lck cDNA 
were introduced into cells by retroviral infection using the biscistronic vector Migr1 
permitting the concurrent expression of a given Lck variants and EGFP. Infected cells 
(3T3-Lck) were sorted out based on the expression of EGFP (Fig. 4.1B) and maintained 
in cell cultures. Protein expression of Lck and RACK1 (Fig. 1C) is comparable among 
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all FACS-sorted 3T3-Lck infectants and were used for further analyses. It is of note that 
3T3 cells do not express endogenous Lck. 
Figure 4.1 Preparation of NIH3T3 fibroblast cell lines expressing comparable levels of 
various Lck mutants.  A. Lck domain structure with indicated point mutations/deletion 
affecting the function of SH3, SH2 and catalytic domains and the regulatory C-terminal region 
is depicted. B. Histogram showing comparable intensity of EGFP expression among Lck 
infectants measured by flow cytometry. C. Western blot analysis performed on total cell lysates 
revealed comparable protein levels of Lck and RACK1 among indicated Lck infectants. 
 
4.3 Kinase active Lck complexes with RACK1 
To determine whether the presence of tyrosine-phosphorylated RACK1 in the 3T3 cells 
co-expressing kinase active Y505F-Lck (see Fig. 2.7) correlates with the ability of Lck 
to interact with RACK1, hemagglutinine-tagged RACK1 (HA-RACK) was  
co-expressed in 3T3 cells with empty vector MIGR1, or MIGR1 encoding either WT or 
C 
A B 
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Y50F-Lck. Cells were lysed (TNE buffer, 1% NP-40) and immunoprecipitated  
HA-RACK1 was probed for Lck, HA-RACK1 and phosphotyrosine (pY) content. As 
illustrated in Fig. 4.2, HA-RACK1 is readily expressed in all 3T3 infectants used 
(bottom panel). Probing anti-HA-RACK1 immunoprecipitate with anti-Lck antibody 
revealed that Y505F-Lck, but not WT-Lck, efficiently co-immunoprecipitates with  
HA-RACK1 (Fig 4.2, top panel). In addition RACK1 complexed with Y505Lck is also 
tyrosine phosphorylated (Fig. 4.2, middle panel). These data are consistent with data 
obtained from 2D-gel analysis and suggest that complex formation between kinase 
active Lck and RACK1 correlates with RACK1 phosphorylation.  
Figure 4.2 Lck is able to interact with RACK1. 3T3 cells infected with WT or Y505F Lck 
were transfected with HA-tagged RACK1.  RACK1 was immunoprecipitated with anti-HA 
antibody and equal aliquots were probed for Lck (upper panel), phosphotyrosine content with 
4G10 mAb (middle panel) and RACK1-HA with anti-HA 12CA5 mAb (bottom panel). 
Constitutive active form of Lck (Y505F) but not WT-Lck, co-immunoprecipitates with 
overexpressed HA-RACK1 which is tyrosine-phosphorylated.  
 
4.3.1 Structure-function analysis of Lck-RACK1 interaction 
Next, we examined whether ectopically expressed Lck also interacts with endogenous 
RACK1 and if yes, whether this interaction is dependent on certain Lck domains or 
functional segments. Endogenous RACK1 was immunoprecipitated with anti-RACK1 
polyclonal rabbit antibody from 3T3 Lck infectants and aliquots of immunoprecipitate 
were blotted for Lck (Fig. 4.3A, upper panel) and RACK1 (Fig. 4.3A, bottom panel). 
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We found that Y505F and Y394F-Lck interact comparably with endogenous RACK1 
and this interaction is slightly diminished in cells expressing the WT-Lck. However, a 
significant reduction in the formation of Lck-RACK1 complexes is observed using SH2 
and SH3 domain mutants as well as the C-terminal Lck truncate (Fig. 4.3A, upper 
panel). Quantification analysis revealed that Lck-RACK1 interaction was ~2-5 fold 
lower compared to that between Y505F and or Y394F-Lck and RACK1. It suggests that 
functional modular domains and the C-terminal tail of Lck are prerequisites for Lck-
RACK1 complex formation. 
Figure 3. RACK1-Lck interaction depends on functional SH3, SH2 and the C-terminal 
domains. A. Endogenously expressed RACK1 was immunoprecipitated from indicated  
3T3-Lck infectants and blotted with anti-Lck (upper panel) and anti-RACK1 (bottom panel) 
antibodies. B) Bar graph shows the relative amount of Lck immunoprecipitated with RACK1 
measured by normalization to the total amount of immunoprecipitated RACK1. As an arbitrary 
reference value was assigned Y505F signal (=1). Blots and graph are representative of three 
independent experiments. 
 
0,08
0,72
1,00
1,33
0,33 0,31
0,53
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
Migr1 WT Y505F Y394F W97K R154K ΔC11
re
la
ti
ve
 d
e
n
si
ty
A 
B 
48 
 
4.3.2 Lck-RACK1 complex formation in primary CD4+ T-cells 
To verify that Lck-RACK1 interaction is not an artefact of fibroblast model system, we 
next determined whether this interaction is detectable under more relevant physiological 
circumstances. We first assess whether RACK1 is expressed in primary lymph node 
CD4
+
 T-cells. Total mRNA isolated from highly enriched CD4
+
 T-cells obtained by 
MACS separation (~95% purity) and further purified by FACS to 99.3% (Fig. 4.4A) 
positive CD4
+
 population was used for RT-PCR analysis. As illustrated in Fig. 4.4B, 
RACK1 is expressed in non-activated CD4
+
 T-cells.  
Figure 4.4 RACK1 is expressed in murine CD4
+
 T-cells. A. Phenotypic profile of CD4
+
  
T-cells obtained by MACS separation followed by FACS sorting. (Red rectangle = 
sorting gate). B. RT-PCR was performed on mRNA isolated from CD4+ lymph node T-cells 
according the protocol and conditions described in the section Material and Methods (3.14). 
 
To determine whether Lck-RACK1 interaction in CD4
+
 T-cells occurs constitutively or 
not, or whether this interaction is activation-inducible, we utilized the recently 
established model of T-cell activation enabling to study the kinetics of interaction 
between two interacting proteins during the first seconds after TCR/CD4 engagement. 
Specifically, primary CD4
+
 T-cells were pre-coated with biotin-conjugated antibodies 
specific for TCRC  and CD4 and activated by the addition of streptavidin. Antibody 
mediated co-aggregation of TCR and CD4 induces robust global tyrosine 
phosphorylation of cellular substrates throughout the co-aggregation time course 
analysed (Fig 4.5).  
A B 
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Figure 4.5 Time dependent phosphotyrosine status upon T-cell activation via  
co-aggregation: Freshly isolated primary CD4
+
 lymph node T-cells were pre-coated, or not 
(control), with biotinylated anti-TCR (H57) and anti-CD4 (GK1.5) mAbs (αTCR/CD4) and  
co-aggregated, or not (0 sec), with addition of streptavidin for time indicated. Phosphotyrosine 
content of cell lysates derived from 0.5x10
6
 cells/sample was probed with 4G10 antibody. One 
representative blot from several independent experiment is shown. 
 
Using this method, T-cell were pre-coated or not (control sample) with biotin-
conjugated antibodies specific for TCRC  and CD4 and activated, or not (0 sec), for 10, 
30, 90 and 270 second. Activation was stopped by directly adding a cold TNE lysis 
buffer, cell lysates were immunoprecipitated using anti-RACK1 antibody and aliquots 
were probed for Lck and RACK1. As illustrated in Fig. 4.6, RACK1-Lck complexes 
were not detected in control sample. However, relatively robust Lck-RACK1 co-
immunoprecipitation signal was observed in antibody pre-coated but not co-aggregated 
(0 sec) sample. Interestingly, intensity of this signal decreased to ~30% of its value over 
the ensuing 270 seconds after TCR/CD4 co-aggregation. In sum, this data suggests that 
in naïve non-activated CD4+ T-cells Lck and RACK1 are not associated. Simultaneous, 
yet independent engagement of TCR and CD4 receptors induces Lck-RACK1 complex 
formation even though T-cells activation per se, as measured by induction of global 
tyrosine phosphorylation, is for this process dispensable.   
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Figure 4.6 Antibody-mediated engagement of TCR/CD4 receptors induces Lck-RACK1 
complex formation. A. Freshly isolated primary CD4
+
 lymph node T-cells were pre-coated, or 
not (control), with biotinylated anti-TCR (H57) and antti-CD4 (GK1.5)  mAbs (αTCR/CD4) 
and co-aggregated, or not (0 sec), with addition of streptavidin for time indicated (in sec). 2x10
6 
cells per each time point were immunoprecipitated with anti-RACK1 and blotted against Lck 
(upper panel) and RACK1 (bottom panel). B. Bar graph shows the relative amount of Lck 
immunoprecipitated with RACK1 measured by normalization to the total amount of 
immunoprecipitated RACK1. The amount of Lck co-immunoprecipitated with RACK1 in cells 
pre-coated with anti-TCR/CD4 but not aggregated was assigned an arbitrary reference value of 
“1”. The figure is representative of two independent experiments.  
 
4.4 Common redistribution dynamics of Lck and RACK1 in activated T-cells 
In previous result sections we presented biochemical data which demonstrate the 
physical interaction between Lck and RACK1 in both fibroblast 3T3 cells and primary 
CD4
+
 T-cells. Next, we wanted to assess whether this interaction can be visualized 
microscopically in form of Lck-RACK1 co-localization. To gain some insight in the 
cellular distribution of both proteins, 3T3 cells and purified primary lymph node CD4
+
 
T-cells were stained with anti-Lck and anti-RACK1 and inspected by confocal 
microscopy. As illustrated in Fig. 4.7, in 3T3 cells, Y50F-Lck (green) preferentially 
localizes at the cell membrane while RACK1 (red) predominantly in cytoplasm where it 
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forms speckle-like structures. No obvious co-localization was observed. Moreover, 3T3 
cells ectopically expressing either W97K-Lck SH3 or C11-Lck mutant, which were 
unable to efficiently bind RACK1, showed similar distribution of these two proteins as 
3T3 Y505F-Lck infectant (data not shown). In naïve unstimulated (control) CD4+ T-
cells, RACK1 fills up the constrained space between the nucleus and plasma membrane 
and Lck localizes exclusively to the plasma membrane. Similar to the situation in 3T3 
cells, Lck-RACK1 co-localization was undetectable.   
Figure 4.7 Distribution of Lck and RACK1 in NIH3T3 cells and freshly isolated primary 
CD4+ lymph node T-cells.  Cells were fixed in 4% PFA and probed with anti-Lck (green) and 
anti-RACK1 (red). One representative sample for each cell type is shown. Nuclei are stained 
with DAPI (blue). (x400 zoom). 
 
To test whether in primary CD4
+
 T-cells the co-localization of Lck and RACK1 is 
depend on TCR-CD4-co-aggregregation, the same “antibody-mediated activation” 
protocol was implied (section 4.3.2 and figure 4.6).  After activation, T-cells were fixed, 
stained for Lck (green) and RACK1 (red) and analysed by confocal microscopy.  
It is of note that αTCR (H57) and αCD4 (GK1.5) are of hamster and rat origin 
respectively and hence do not cross-react with secondary antibodies used in this assay. 
In control cells, non-precoated with Abs against TCR, CD4, Lck and RACK1 were 
evenly distributed within the cell membrane and cytoplasm, respectively (Fig. 4.8A). 
Upon TCR/CD4 co-aggregation, we observed a time-dependent co-redistribution of Lck 
and RACK1 into a restricted subcellular compartment in approximately 50% of all cells 
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analysed (Fig. 4.8B). Formation of similar microscopic structures after antibody-
mediated crosslinking of T-cell receptor(s) called “capping” has been already described 
(Kupfer and Singer, 1988). Co-capping of Lck and RACK1 peaks at 30 to 90 seconds 
after TCR/CD4 co-aggregation (Fig. 4.8A). However, three minutes after activation, 
Lck distribution returned to its initial, pre-activation state (nearly even membrane 
distribution), while RACK1 was retained clustered (Fig. 4.8A, bottom images). 
 
Figure 4.9 Lck and RACK1 co-redistribute into forming immunological synapse (IS) 
during early phases of CD4
+
 T-cell/APC interaction. Bone marrow derived-dendritic cells 
(BMDC) and -macrophages (BMMF) generated from MHCII-EGFP knock-in mice were pulsed 
with OVA peptide and mixed with lymph node-derived CD4
+
 T-cells isolated from OTII 
transgenic mice (with TCR specific for OVA peptide). After approximately 2-3 minutes,  
T-cell/APC conjugates were seeded on a cover slip, fixed with 4% PFA and probed with anti-
Lck (green), anti-RACK1 (red). MHCII-EGFP molecules expressed on the surface of APCs are 
in yellow (it is of note however, that this expression is very weak on BMMF and some BMDC 
cells). Arrows point to forming IS. Representative images are shown. Nuclei are stained with 
DAPI (blue).  (x400 zoom). 
 
Redistribution of Lck and RACK1 was also examined in more physiological conditions, 
during early phases of immunological synapse formation. Bone marrow-derived 
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dendritic cells and macrophages pulsed with OVA peptide were mixed with transgenic 
T-cells specific for OVA peptide, and allowed to form conjugates. The cells were then 
fixed and immunostained for Lck (green) and RACK1 (red). Microscopic analysis 
showed that Lck and RACK1 concomitantly translocated to IS at early phases of its 
formation (2-3 minutes) (Fig. 4.9). Taken together, these data (Fig. 4.8 and 4.9) suggest 
that T-cell activation induces a rapid, cooperative and membrane-directed movement of 
Lck and RACK1. This co-redistribution pattern further strengthened the original 
suggestion that RACK1 is a member of translocation machinery regulating the 
distrubution of membrane Lck.  
 
4.5 Subcellular distribution of Lck complexes  
As reported previously, Lck prepared from unstimulated resting CD4
+
 T-cells by 
solubilization with non-ionic detergent Brij-58 is highly enriched in soluble cellular 
fractions. Upon activation, 10-30% of Lck from this soluble pool is found translocated 
to lipid rafts (Filipp et al, 2003). As RACK1 is likely to be involved in this translocation 
process, we decided to characterize this translocating pool of Lck in greater detail. The 
main idea was to fractionate cellular components, first according to their size, and 
couple this step to their subsequent LR fractionation. This approach was expected to 
provide an insight into a size-dependent distribution of Lck complexes to LR. First, we 
adopted a gel filtration chromatography protocol (size exclusion chromatography) 
(Cinek and Horejsi, 1992) to identify size of Lck complexes over its elution profile (Fig. 
4.10A, top 3
rd
 panel). Results demonstrate the existence of Lck-associated complexes 
with significant differences in their size, ranging approximately between 10-100 to more 
than 1000 kDa (Fig.4.10A, size marker on the top). As illustrated in fig. 4.10A top two 
panels, LR-surrogate marker GM1 and LR-resident Fyn kinase co-fractionate with high 
molecular weight fractions (HMWFs) #4-5.  
To assess the LR-distribution of Lck-associated molecular complexes, fraction number 
4+5, 6+7, 8+9 and 9+10 were pooled and subjected to sucrose gradient floatation assay 
(SGFA) (Fig.4.10B). Result shows that only a small portion of Lck from HMWF #4-5 
partitions to LR (~5-20%) while Lck from intermediate and low MW fractions (#6-12) 
is detected in soluble fractions exclusively. Fyn, which associated exclusively with 
HMWF #4-5 (Fig.4.10A 2
nd
 top panel), is detected only in LR fractions (Fig.4.10B, 
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bottom panel). Interestingly, RACK1, which is preferentially associated with HMWFs 
#4-6 (Fig 4.10A, bottom panel), is undetectable in any of the fractions after SGFA (data 
not shown).  
Figure 4.10 Distribution of high molecular weight complexes-associated Lck in lipid rafts. 
A. Fractionation of CD4
+
 T-cells lysed in TKM+0,5% Brij58 buffer using a Sephadex gel 
filtration chromatography. Lck-containing fractions (4-12) were resolved on 9% SDS-PAGE 
gel, transferred onto PVDF membrane and probed with cholera toxin B subunit-HRP detecting 
lipid raft marker GM1 (upper panel), anti-Fyn (2
nd
 from the top panel), anti-Lck (3
rd 
from the 
top panel) and anti-RACK1 (bottom panel). Approximate molecular weight size marker is 
shown on the top. B. Sucrose gradient flotation assay of pooled fractions (as indicated) obtained 
from gel filtration chromatography. Lipid raft-containing fraction #1 (R) and soluble protein 
enriched fraction #10 (S) were probed with anti-Lck (upper panel) and anti-Fyn (bottom panel). 
Blots are representative of three independent experiments. 
 
4.6 Lck associated with HMW-complexes translocates to lipid rafts. 
To determine which type of Lck-associated complexes translocate to LR upon 
TCR/CD4-mediated activation, fractions from CD4
+
 T-cells activated or not for 30 
seconds by TCR/CD4 co-aggregation and prepared by gel filtration, were pooled (#4-5 
and #6-7) and were subjected to SGFA as described in the previous section. As 
illustrated in Fig. 11A, and consistent with previous experiments, only a small 
A 
B 
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proportion (~10%) of HMWF-associated Lck (#4-5) from unstimulated T-cells portions 
to LR (Fig. 4.11A, top panel). Antibody-mediated activation induced translocation of 
more than 50% of Lck from HMWFs (#4-5) to LR. On the other side distribution of Lck 
from intermediate molecular weight fractions (#6-7) remained unchanged, and Lck was 
detected exclusively in soluble fractions. Taken together, this data strongly suggest that 
upon activation, only the pool of HMWF-associated Lck is targeted to LR. Moreover it  
 
Figure 4.11 High molecular weight-associated Lck translocates to lipid rafts upon T-cell 
activation. A. Primary CD4+ T-cells, pre-coated with biotinylated anti-TCR and anti-CD4 
antibodies, were activated, or not (0 sec) by addition of streptavidin for 30 seconds and 
immediately lysed in a cold TKM+0,5% Brij58 buffer. High (4-5) and intermediate (6-7) 
molecular weight fractions prepared by gel filtration were subsequently subjected to sucrose 
gradient flotation assay. Equal aliquots of LR fractions (1-3, R) and soluble fractions (8-10, S) 
were probed with anti-Lck. B. Bar graph represents the percentage distribution of Lck in lipid 
rafts in high and intermediate molecular weight fractions before and after antibody-mediated 
activation of T-cells as measured by Western blot signal densitometry. Blots are representative 
of 3 independent experiments. 
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indicates that RACK1 which is able to inducibly interact with Lck (Fig. 4.6) and  
co-fractionates with HMWFs, can participate in Lck translocation process. 
 
4.7 RACK1 co-localizes with microtubular network  
Cytoskeleton plays a critical role in T-cell activation (Gomez and Billadeau, 2008). To 
investigate whether RACK1 can be involved in Lck translocation through its binding to 
cytoskeleton component(s), we assessed the capacity of RACK1 to co-localize with 
actin, vimentin or microtubulin cytoskeletal components. NIH3T3 cells were fixed with 
PFA and immunostained with anti-RACK1 in combination with antibody directed 
against the one of three above mentioned cytoskeleton components – actin, vimentin 
and α-tubulin. Data obtained suggest that neither actin nor vimentin co-localize with 
RACK1 (Fig. 4.12A, B). In contrast, α-tubulin and RACK1 co-localize to speckle-like 
structures detected inside the cell (Fig. 4.12C, D).  
Interestingly, while anti-tubulin antibody revealed predominantly fibrilar structure of 
microtubular network, it seems that brightly stained RACK1 structures co-localize with 
relatively brightly stained spots appearing along the microtubular fibrils, forming thus a 
sort of a regular RACK1-α-tubulin “nodal” network. While the nature, distribution and 
functional importance of such a network is not obvious, it suggests that involvement of 
RACK1 in Lck translocation could be mediated through its interaction with 
microtubular cytoskeletal network. However, whether RACK1 and microtubular 
network also co-localize in primary CD4
+
 T-cells, remained to be defined. 
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Figure 4.12 RACK1 co-localizes with tubulin but not with actin and vimentin. 3T3 cells 
fixed with 4% PFA were probed with A. phalloidine (red) and anti-RACK1 (green) B. anti-
vimentin (green) and anti-RACK1 (red) C. anti-tubulin (green) and anti-RACK1 (red).    
D. Magnified image of RACK1 (red) –microtubulin (green) co-localizations.  Arrows point to 
speckle-like structures formed by co-localized proteins. Nuclei were stained with DAPI (blue) 
(x400 zoom). 
  
D. 
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5 Discussion 
T-cells are a prototypical example of highly sophisticated and precisely regulated 
signalling cells. Signalling through T-cell antigen receptor (TCR) has the potential to 
trigger a broad range of cellular responses. Two Src family tyrosine kinases (SFK) - Lck 
and Fyn - provide critical functions that predicate the generation of the most proximal 
signals emanating from the TCR (Filipp and Julius, 2004). It has been recently 
demonstrated that lipid raft (LR) plays an essential role in temporal and spatial 
coordination of these two kinases (Filipp et al., 2004; Filipp et al., 2003). Specifically, 
TCR-CD4 co-aggregation-induced Lck activation outside LR results in Lck 
translocation to LR where the activation of LR-resident Fyn ensues. Central in this 
sequence of events is the rapid translocation and subsequent enrichment of kinase active 
Lck in LR. While this process of Lck recruitment to LR is indispensable for T-cell 
activation, the mechanism underpinning this event is unknown.  
The overarching goal of our investigation presented in this thesis was the 
characterization of the molecular mechanism, and its/their functional elements, 
regulating the early recruitment of signalling molecules to LR and forming 
immunological synapse. We addressed this task by focusing specifically on cis- and 
trans-acting elements regulating the process of Lck recruitment to LR. Preliminary data 
obtained in our laboratory (see the section 2.9) provided a compelling evidence for the 
existence of proteins regulating this critical aspect of Lck physiology. Notably, it 
pinpointed the receptor of activated C kinase (RACK1) protein as candidate molecules 
regulating spatial distribution and translocation of T-cell signalling kinases in trans. 
They also demonstrated the involvement of Lck C-terminal sequence (in cis) in 
targeting Lck to LR likely via tethering directly to cytoskeletal elements (Filipp et al., 
2008). As targeting Lck to LR predicates enhanced TCR mediated IL-2 production 
(Filipp et al., 2008) and alternations in the association of Lck and other accessory 
molecules with LR support abnormal T-cell signalling in autoimmune diseases (Jury et 
al., 2004), elucidation of the nature of this process on a molecular level represents a 
topic of great scientific and clinical interests.  
Potential members of translocation machinery were originally identified using a 
screening strategy based on difference in phosphorylation status of cellular proteins 
present in NIH3T3 fibroblast cell line expressing either a full size or C-terminal truncate 
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mutant ( FQPQP) of kinase active Y505-Lck (2-D gels, Fig. 2.7). Notably, several 
hypo-phosphorylated proteins derived from FQPQP-Lck expressing cells and resolved 
on 2D gels, were recognized. It is important to emphasize that FQPQP-Lck, that 
retains kinase activity, displayed a 60-80% reduction in their partitioning to LR (Filipp 
et al., 2008). So, as targeting of FQPQP-Lck to LR is compromised, the 
hypophosphorylated proteins could be downstream targets of kinase active Lck 
responsible for its translocation process presumably through direct interactions with 
cytoskeletal elements. 
One of the candidate protein selected by this screening process was identified as 
RACK1. Initial search for available information in public databases revealed that 
RACK1 fulfils the main requirement expected from the member of Lck translocation 
machinery: it consists of modular domains able to function as a linker or scaffold 
sequences for interaction with other proteins; (ii) it is a substrate for SFK Src and also 
can interact with Lck (Chang et al., 1998); (iii) it is involved in the intracellular 
translocation processes (Ron et al., 1999); and importantly (iv) is able to interact with 
cytoskeletal components (Osmanagic-Myers and Wiche, 2004). All these characteristics 
led us to investigate the ability of RACK1 to interact with Lck and the function of 
RACK1 in the context of Lck translocation mechanism in CD4
+
 T-cells. 
Experimental data presented in this study are the first to reveal and characterize the role 
of RACK1 in T-cell activation, in general, and in proximal TCR signalling, specifically. 
Co-expression in NIH3T3 cells of HA-tagged RACK1 with Lck variants revealed that 
constitutively active Y505F-Lck, but not WT-Lck, complexes with RACK1. This 
suggests that RACK1 preferentially binds the activated form of Lck. Structure-function 
analysis performed on NIH3T3 infectants ectopically expressing Y50F-Lck with its 
domain-inactivating mutations showed that Lck-RACK1 interaction depends on 
functional SH2 and SH3 domains and the C-terminal tail sequence of Lck. Importantly, 
Lck-RACK1 complex formation is detectable in primary CD4
+
 lymph node T-cells and 
wanes shortly after activation. Remarkably, while this complex formation is induced by 
TCR/CD4 ligation it does not require an induction of global tyrosine phosphorylation 
regarded as an early biochemical marker of proximal TCR signalling.  
Upon T-cell activation, only the pool of Lck molecules associated with the high 
molecular weight fractions (HMWFs) translocates to lipid rafts. Co-purification of 
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RACK1 with these fractions correlates with its possible involvement in the mobilization 
of Lck to LR. In addition, Lck and RACK1 co-redistribute with the same kinetics to 
both antibody-induced capping clusters and forming immunological synapses. This 
argues for the existence of a mechanism by which Lck and RACK1 are physically 
coupled and mechanistically transferred to these structures, perhaps by binding to some 
element(s) of cytoskeletal network. Recent demonstration that RACK1 is able to bind 
the cytoskeletal proteins (Osmanagic-Myers and Wiche, 2004) warranted an 
investigation into the RACK1-mediated regulatory mechanism underpinning 
cytoskeleton-controlled translocation of Lck to LR. In this context it is of interest that 
Lck was shown to be associated with cytoskeletal system (Louie et al., 1988). Our 
confocal microscopy data showed that RACK1 co-localizes with microtubulin 
component of cytoskeleton. As this is the first report of microscopically observed 
association between RACK1 and microtubulin, the nature and precise mechanism(s) of 
this co-localization is unknown at present time. Thus, in aggregate, our data strongly 
suggests that RACK1 is an adaptor protein involved in the regulation of Lck 
translocation to LR through providing a scaffold function linking Lck to the 
microtubular cytoskeletal network.  
It is clear that while this investigation provided some answers and clues to our original 
questions regarding the nature, elements and mechanism of Lck mobilization to LR, it 
also raised many questions the answers to which are unknown at present time. We will 
discuss these points below.  
First point relates to RACK1 domain structure and its ability to interact with Lck. It has 
been reported that the 6
th
 WD40 domain of RACK1 binds directly to SH2, but not SH3 
domain of Src (Chang et al., 2001). As Src and Lck share the same structural 
components and domain organization, we have assumed that RACK1-Lck interaction 
should be also dependent on SH2 domain of Lck. We have also predicted that based on 
the strategy of our screening protocol, the C-terminal mutant can contribute to this 
binding. Unexpectedly, in addition to these two domains, RACK1 was also largely 
abrogated with SH3-inactivated SH3 mutant of Lck. This suggests an equal importance 
of all three implicated domains in Lck-RACK1 binding. However, while Src-RACK1 
interaction is modelled through binding of Src-SH2 domain to the tyrosine in position 
246 (Y246) in 6
th
 WD40 domain phosphorylated by Src itself (Chang et al., 2002), 
structural bases for RACK1 binding to SH3 and the C-terminal tail sequences, awaits 
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elucidation. At this time, we can only speculate that if the binding is direct, SH3 can 
potentially bind to proline-rich sequences present in RACK1 (Ballek and Filipp, 
unpublished data). If this interaction is mediated through some intermediary, it would 
predict a formation of multiprotein complex involving multiple protein-protein 
interactions. We posit that regardless of the size of this complex, involvement of SH2, 
SH3 and the C-terminal tail sequences of Lck will be required for its full formation and 
function. Clearly, more experiments have to be done to explain the involvement of all 
three Lck domains in the context of complex formation with RACK1. Moreover, 
whether the involvement of the three Lck domains also relates to its activation-induced 
translocation process to LR observed in primary CD4+ T-cells, remains to be 
determined.   
As expected, transcripts of RACK1 are readily detectable in primary murine CD4
+
 T-
cells. This finding correlates with data available in the Expression profile databases 
(SymAtlas, http://symatlas.gnf.org), which indicates a relatively high level of RACK1 
expression in CD4
+
 and CD8
+
 T-cells.  
The second discussion point relates to the mechanism of induction of Lck-RACK1 
interaction in primary CD4
+
 T-cells. Structure-function analyses based on the co-
immunoprecipitation of Lck and RACK1 from fibroblast cell line turned out to be 
informative. To assess whether Lck-RACK1 interaction occurs during Lck translocation 
to LR in early stages of proximal T-cell signalling, we adopted the protocol of antibody-
mediated activation of CD4
+
 lymph node T-cells. When this protocol is applied, Lck 
translocation to LR peaks at about 30 seconds after TCR-CD4 co-aggregation (Filipp, 
2003).  
As illustrated in Fig 4.6, complex formation between Lck and RACK1 in 
unmanipulated control sample was not observed. However, the most robust Lck-
RACK1 immunoprecipitation signal was detected in anti-TCR+anti-CD4 pre-coated T-
cells which were not stimulated by co-aggregation of these receptors. The complex 
formation signal gradually diminished over the time of stimulation (Fig.4.6). 
Interestingly, the pre-coating procedure itself did not result in increase of global 
tyrosine phopsphorylation (Fig.4.5, 0 sec sample). This indicates that (i) pre-coating the 
T-cells wiht anti-TCR and -CD4 antibodies is sufficient to induce RACK1-Lck 
interaction and (ii) RACK1 protein under these conditions does not become tyrosine 
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phosphorylated. These data, unfortunately, disallowed us to distinguish whether  
pre-coating of TCR or CD4 alone can induce Lck-RACK1 complex formation. 
However, as Lck associates with CD4, it is quite likely that the ligation of CD4 triggers 
subtle changes in Lck conformation not accompanied by its auto/trans phophorylation, 
what in turn leads to Lck-RACK1 binding. It is plausible that these conformational 
changes involve the release of the C-terminal tail of Lck from its „tuck-in” 
conformation, making it available for interaction with RACK1. This is quite attractive 
model, as Lck binding to RACK1 would be initiated upon engagement of CD4 without 
any apparent attributes of cellular activation. In this sense, CD4 receptor would function 
as a mechano-receptor sensing the presence of APCs through recognition of MHCII and 
thus preparing T-cells for the potential receipt of full activation signal via connecting 
Lck with cytoskeletal network. However, it is also important to note, that translocation 
of Lck to LR can proceed only after coordinated engagement of CD4 and TCR to 
pMHC (Filipp et al., 2003). Thus, mechanism of Lck translocation to LR can be 
modelled as a two-step process: (i) transient engagement of CD4 receptor to MHCII 
during the scanning of APCs for a cognate ligand leads to “wiring” of Lck to the 
cytoskeletal network; this first step is independent of global increase in tyrosine 
phosphorylation; (ii) once simultaneous engagement of CD4 and TCR occurs, kinase 
active Lck is rapidly immobilize to LR and RACK1 gradually disengages from Lck.  
The model suggested above is consistent with the kinetics of Lck translocation to LR: 
co-aggregation induced Lck enrichment in LR reaches its maximum at 30 seconds, what 
correlates with the maximum decrease in the amount of detectable Lck-RACK1 
complexes (Filipp et al., 2003). 
The third discussion point concerns the distribution of Lck and RACK1 and their  
co-redistribution induced upon activation of T-cells. In resting T-cells, Lck is localized 
to the plasma membrane (PM) whereas RACK1 is localized in the cytoplasm. A closer 
analysis revealed a narrow area of their overlay just underneath of PM. That suggests 
that Lck and RACK1 are position in a way allowing them to interact rapidly and 
efficiently. Upon T-cell activation, we observed a relatively rapid displacement of these 
proteins toward the same subcellular location characterized as “capping” structures and 
immunological synapses in CD4
+
 T-cells and in CD4
+
 T-cell:APC conjugates, 
respectively. Interestingly, coordinated movement of Lck and RACK1 resulted in their 
only marginal co-localization (Fig. 4.9). This is consistent with the fact that only 5-25% 
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of cellular Lck is translocated to LR after activation (Filipp et al., 2003) while the vast 
majority of Lck associates with soluble fractions. Further, the common pattern of re-
distribution suggests that the underlying mechanism is shared by Lck and RACK1. That 
in turn indicates that both molecules, being associated with each other, are also attached 
to a common translocating device, presumably to a certain type of cytoskeletal network. 
RACK1 has been previously described as a carrier protein involved in the mobilization 
of PKCβII after activation with PMA, giving a precedence for being involved in 
processes of regulated intracellular translocation (Ron et al., 1999), However, as 
RACK1-mediated PKCβII and Lck translocation processes display distinct nature, 
localization, mechanism and kinetics, it would be of interest to understand how different 
interacting partners and surrounding cellular environment affect these distinct 
translocation events. 
The forth point of discussion is focused on the pool of Lck subjected to LR 
translocation. Our data demonstrate that only HMWF-associated Lck, with the size 
bigger than 1000 kDa, is involved. RACK1 co-purifies with the HMWF, suggesting its 
association with translocation process. However, we were not able to detect RACK1 in 
neither the LR nor soluble fractions after SGFA, what suggests that RACK1 
concentrates in pellet fraction after nuclei centrifugation. As a matter of fact, the yield 
of RACK1 obtained from cell lysates using 1% of NP-40 is relatively small (~10-20% 
of the total), indicating that RACK1 could be tightly bound to the cytoskeleton. 
Perhaps, detergents used for isolation of LR (Brij58, NP-40) are too mild to disrupt 
RACK1-cytoskeleton complexes. As their size is >1000 kDa, it suggests existence of 
multiprotein RACK1 complexes. Immunoprecipitation of these complexes and 
characterization of their components will pave the way for further advancement of this 
field. 
And lastly, the fifth discussion point relates to the cytoskeleton as a very important part 
of living cells regulating most movements and translocation processes. In T-cell it has 
been shown that cytoskeleton plays a role in distribution of proteins within the cell 
membrane and is essential in formation of immunological synapse (Billadeau et al., 
2007). It is mainly F-actin that regulates membrane protein movements and relocations 
(Viola and Gupta, 2007). Some membrane proteins capable of interaction with F-actin 
were identified: filamin A, ezrin, moesin) (Tavano et al., 2006). However, translocation 
processes dependent on F-actin and its polymerization become evident only during 
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formation of immature IS, several minutes after initiation of activation process. Hence, 
F-actin is an unlikely candidate involved in Lck translocation process which happens 
rapidly within 30 seconds after activation. Our attempt to identify RACK1 interacting 
cytoskeletal component showed co-localization pattern with microtubulin network 
(MTN). The signal overlay pattern forms small, speckle-like structures, indicating, that 
these structures likely represent some kind of vesicles or complexes, rather than 
growing end of microtubules. Importance of this finding is further strengthened by the 
fact that microtubules are associated with several distinct processes regulating T-cell 
function. For example, it has been shown that upon T-cell activation, Microtubule 
organizing centre (MTOC) rapidly reorients towards IS at T-cell:APC contact zone and 
microtubules serves as a railway delivering its cargo to this interface. Interestingly, 
cooperation of microtubules with F-actin has been also previously described and their 
association with LR has been suggested (Salmon et al., 2002). 
Association of RACK1 with microtubulin cytoskeleton has not been previously reported 
and thus represent the point of our immense research interest. In addition, MTN has not 
been up untill now implicated in proximal phases of T-cell signalling. At present time, it 
is completely obscured how the interaction between MTN and RACK1 is maintained, 
what mechanism regulates it and what is the kinetics and dynamics of this interaction. 
Even though we exercise the caution in extrapolating results obtained in fibroblasts cells 
to CD4+ T-cells, we believe that these data provide a solid platform for initiation of 
studies elucidating these original findings.   
Data presented in this study revealed an unappreciated complexity of mechanism 
controlling one of the most crucial step in proximal T-cell signalling surrounding the 
process of Lck translocation to LR. This process, originally studied as a mechanism 
controlling coordinated and sequential activation of Lck and Fyn through involvement 
of LR, unearthed the existence of mechanism regulating first seconds of activation of T-
cells. Identification of RACK1 as the first member of membrane translocation 
machinery, characterizing its role as a scaffold protein linking the engagement of TCR 
and CD4 receptors with the process of Lck binding to MTN, opens a whole new area of 
research in proximal T-cell signalling.  
Results presented here are in agreement with and further extend the current model of 
Lck translocation. They also provide further details about the molecular elements, 
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mechanisms and regulation of activation-induced translocation of Lck to LR. Whether 
this model can be extended to other signalling elements and scenarios with LR 
translocation phenotype, remains to be tested.  
To elucidate physiological role of RACK1 in T-cell activation, we plan to generate 
primary T-cells where the function of RACK1 will be ablated via expression of shRNA 
or genetically by constructing the conditional T-cell RACK1 knock-out mice. We will 
also examine the involvement of microtubular cytoskeleton components by their 
pharmacological inhibition. It is critical to identify and characterize other members and 
interacting partners of RACK1 translocation machinery. From perspective point of 
view, detail characterization of these elements regulating targeting of Lck and other 
signalling molecules to lipid rafts could provide new protocols for treating immune 
disorders by downregulating T-cell immune responses.  
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